表紙
市場調查報告書

到2024年預計將出現新的冠狀病毒感染(COVID-19)相關產品和服務的全球市場

COVID-19 Mitigation Products (PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, and More) Market Research to 2024

出版商 Homeland Security Research Corporation (HSRC) 商品編碼 955004
出版日期 內容資訊 英文 1020 Pages; 738 Tables & Figures
商品交期: 最快1-2個工作天內
價格
到2024年預計將出現新的冠狀病毒感染(COVID-19)相關產品和服務的全球市場 COVID-19 Mitigation Products (PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, and More) Market Research to 2024
出版日期: 2020年08月26日內容資訊: 英文 1020 Pages; 738 Tables & Figures
簡介

在全球大流行的背景下,一個新市場,與大流行相關的新的冠狀病毒感染(COVID-19)產品和服務市場正在興起。根據情景,預計2020年至2024年的累計市場規模將為1.6萬億美元(樂觀情景)和2.2萬億美元(保守情景)。

大流行的未來是不可預測的,因此本報告包括兩種情況。

  • 樂觀的情況:預計大規模免疫將在2021年7月開始
  • 保守的情況:假設直到2024年7月才能進行大規模疫苗接種

本報告調查並分析了全球新的冠狀病毒感染(COVID-19)相關產品/服務市場,並概述了COVID-19,相關產品/服務市場,行業市場,區域市場和國家。我們提供有關其他市場的系統信息。

目錄

COVID-19大流行相關產品市場:第1卷:

第1章市場定義

第2章執行摘要

第3章COVID-19(SARS-CoV-2)大流行

第4章市場推廣者

第5章市場障礙

第7章商業機會和挑戰

第8章COVID-19大流行相關行業

第9章COVID-19大流行相關產品行業:五力分析

世界市場

第10章全球COVID-19大流行相關市場

COVID-19大流行相關產品市場:第2卷

產品/服務市場

第1章COVID-19疫苗市場

第2章COVID-19感染後治療藥物市場

第3章其他製藥行業產品-COVID-19大流行相關市場

第4章PCR檢測設備/軟件--COVID-19大流行相關市場

第5章機器人PCR檢測系統軟件--COVID-19大流行相關市場

第6章PCR試劑/消耗品-COVID-19大流行相關市場

第7章鼻試劑-COVID-19大流行相關市場

第8章自我恢復PCR測試套件-COVID-19大流行相關市場

第9章血清檢測試劑盒-COVID-19大流行相關市場

第10章輔助溫度計-COVID-19大流行相關市場

第11章X射線檢查--COVID-19大流行相關市場

第12章CT檢查-COVID-19大流行相關市場

第13章超音波檢查-COVID-19大流行相關市場

第14章FDG-PET/CT檢查/廢水檢查--COVID-19大流行相關市場

第15章PACS/遠程輻射--COVID-19大流行相關市場

第16章PPE袍-COVID-19大流行相關市場

第17章Gloves-COVID-19大流行相關市場

第18章口罩-COVID-19大流行相關市場

第19章:醫學防護罩-COVID-19大流行相關市場

第20章眼睛防護-COVID-19大流行相關市場

第21章PPE滅菌:系統和消耗品-COVID-19大流行相關市場

第22章手部/表面消毒劑-COVID-19大流行相關市場

第23章去污-COVID-19大流行相關市場

第24章其他個人防護設備-COVID-19大流行相關市場

第25章人工智能/大□□數據/深度學習-COVID-19大流行相關市場

第26章家庭醫療IT --COVID-19大流行相關市場

第27章地理監視系統服務-COVID-19大流行相關市場

第28章E-Health-COVID-19大流行相關市場

第29章區塊鏈技術-COVID-19大流行相關市場

第30章其他ICT --COVID-19大流行相關市場

第31章非侵入式呼吸器-COVID-19大流行相關市場

第32章:侵入式呼吸器-COVID-19大流行相關市場

第33章:下一代呼吸器-COVID-19大流行相關市場

第34章家庭 "ICU" (設備/軟件/服務)--COVID-19大流行相關市場

第35章急診醫院-COVID-19大流行相關市場

第36章腎臟透析-COVID-19大流行相關市場

第37章ECMO支持--COVID-19大流行相關市場

第38章其他強化治療方式-COVID-19大流行相關市場

第39章褂子製造工廠-COVID-19大流行相關市場

第40章全球製造工廠-COVID-19大流行相關市場

第41章口罩製造工廠-COVID-19大流行相關市場

第42章面罩製造工廠-COVID-19大流行相關市場

第43章血清檢測試劑盒製造工廠--COVID-19大流行相關市場

第44章熔噴PPE織物製造工廠-COVID-19大流行相關市場

第45章紡粘PPE織物製造工廠-COVID-19大流行相關市場

第46章自恢復PCR檢測試劑盒生產工廠--COVID-19大流行相關市場

第47章人工呼吸器製造工廠--COVID-19大流行相關市場

第48章PCR試劑製造工廠--COVID-19大流行相關市場

第49章PCR測試系統製造工廠--COVID-19大流行相關市場

第50章鼻/口拭子製造工廠-COVID-19大流行相關市場

第51章醫用玻璃和其他製造工廠-COVID-19大流行相關市場

第52章研發設備/耗材-COVID-19大流行相關市場

第53章醫用玻璃和其他產品/服務-COVID-19大流行相關市場

COVID-19大流行相關產品市場:第3卷:

按行業劃分的市場

第1章醫院/外科醫院-COVID-19大流行相關市場

第2章臨床實驗室--COVID-19大流行相關市場

第3章診所--COVID-19大流行相關市場

第4章緊急醫療服務(EMS)--COVID-19大流行相關市場

第5章家庭護理/護理設施-COVID-19大流行相關市場

第6章研究機構-COVID-19大流行相關市場

區域市場

第7章北美--COVID-19大流行相關市場

第8章歐洲COVID-19大流行相關市場

第9章亞太地區-COVID-19大流行相關市場

第10章中東/非洲/拉丁美洲--COVID-19大流行相關市場

鄉村市場

第11章USA-COVID-19大流行相關市場

第12章加拿大-COVID-19大流行相關市場

第13章UK-COVID-19大流行相關市場

第14章德國-COVID-19大流行相關市場

第15章法國-COVID-19大流行相關市場

第16章意大利-COVID-19大流行相關市場

第17章其他歐洲COVID-19大流行相關市場

第18章印度-COVID-19大流行相關市場

第19章中國-COVID-19大流行相關市場

第20章韓國--COVID-19大流行相關市場

第21章日本--COVID-19大流行相關市場

第22章其他亞太地區--COVID-19大流行相關市場

第23章世界COVID-19大流行相關市場的其他區域

COVID-19大流行相關產品市場:第4卷:

附錄

第1章附錄1:常見流感和冠狀病毒之間的異同

第2章附錄2:醫療專業人員用於冠狀病毒的PPE

第3章:附錄3:眼睛保護-CDC供應優化策略

第4章附錄4:隔熱服-CDC供應優化策略

第5章附錄5:口罩CDC供應優化策略

第6章附錄6:N95呼吸器-CDC供應優化策略

第7章附錄7:CDC成人疫苗價格表

第8章附錄8:CDC COVID-19生物安全指南

第9章附錄9:2020年保護醫療工作者的全球絕望

第10章附錄10:與COVID-19對應的消毒程序

第11章附錄11:COVID-19美國醫療服務刺激計劃,2020年4月

第12章附錄12:歐洲對新興流行病的應對

第13章附錄13:CDC/FDA的COVID-19診斷測試開發和法規

第14章附錄14:美國國防生產法:FEMA COVID-19供應鏈穩定示例

第15章附錄15:全球傳染病防制研究合作(GLOPID-R)

第16章附錄16:COVID-19臨床數據的比較(按國家/地區)

第17章附錄17:用於家庭醫療的IT

第18章附錄18:PCR測試和抗體測試之間的區別

第19章附錄19:COVID-19大流行對世界經濟的影響

第20章附錄20:COVID-19檢查

第21章附錄21:GeneXpert平台在WHO世界衛生組織中的作用

第22章附錄22:縮寫

第23章附錄23:詞彙表

第24章附錄24:參考

第25章調查方法

第26章免責聲明和版權

目錄

Title:
COVID-19 Mitigation Products
(PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, AI, Personal Protection Gear, Teleradiology, Eye Protection, Ultrasound, Dialysis, CT, X-Ray, Blockchain Technologies, Medical Glass, Telemedicine, Face Shields, Gowns, Homecare, Gloves, E-Health, Robotic PCR, Antigen Test, Monoclonal Antibody, Face Masks, Therapeutic Drugs, ICU, PACS, PPE Sterilization and More) Market Research, to 2024.

On the backdrop of the global pandemic, a need for essential pandemic mitigation products and services emerged a new market, the COVID-19 Pandemic Mitigation Products Market.

"the COVID-19 Mitigation Products Market is a Seller's Market.....This does not happen Very Often"

To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:

  • 1. Optimistic scenario - assumes (among other things) that mass vaccination will commence by July 2021
  • 2. Conservative scenario - assumes (among other things) that no mass vaccination will be available until July 2024

According to the report scenarios, the cumulative 2020-2024 market* size is expected to be $1.6 Trillion (scenario A, the optimistic one) and $2.2 Trillion (scenario B, conservative).

Market revenue is forecasted to reach at 2020-2024: $1.6 Trillion (scenario A); $2.2 Trillion (senario B)

(*) Market size is year and scenario dependent.

Why trust this report?

  • The team which created this report was led by ex-executives of the medical industry and bio-security experts
  • The team has published since 2006, 36 Pandemic related market reports
  • Team members managed since 1974 medical industry companies, sales & marketing, and R&D departments
  • As the COVID-19 pandemic knowledge changes all the time, we update the report once a month

Bottom Line: While other COVID-19 market reports are written (at best) by MBAs, this report is published by seasoned professionals for industry executives.

"It's your worst nightmare, the perfect storm. .....when I say unprecedented, I mean dating back to the 1818 historic pandemic..... I think 50 years from now, people are going to be reflecting historically on this, the we used to reflect on the 1918 outbreak." Anthony Fauci, National Institute of Allergy and Infectious Diseases director, July 2020.

As we write this report, billions, the largest part of the globe's populace, are restricted to their homes or subject to social distancing, in an effort to contain one of the most terrible plagues of modern times. Trade and industry activity has dropped, millions are out of work, and whole industries have ground to a halt.

Quite understandably, a couple of issues are on your mind:

  • How can my company help out in the global endeavor to mitigate the pandemic?
  • Do this crisis open new business opportunities to my organization?
  • How will I know which opportunities are best to my company?

The intention of this report is to give you the answers to these questions!

The COVID-19 pandemic exposed acute deficiencies of many essential products and services, from PPE & ventilators to surge ICUs and homecare equipment, from PCR reagents to digital contact tracing systems. Never before has world leading healthcare communities been faced with the likelihood of having to ration or function without critical medical supplies and services on this magnitude.

In the beginning, it took 62 days for COVID-19 to infect 10,000 people.... On July 23rd it took only 55 minutes to infect 10,000. A growth rate of 1,653% ! No wonder trillions will be invested to save people and the economy.

COVID-19 Pandemic Mitigation Products & Services Market Segmentation Vectors

5 Regions, 13 National Markets, 6 Vertical Markets,
and 4 Revenue Source Markets:

54 Products and Services Markets:

The COVID-19 Mitigation Products Market Research presents a thorough market analysis of 54 products & services, 6 end user, 4 revenue source, 5 regional and 13 national markets. Furthermore, the report provides updated extensive data of 37 key vendors.

This 1035-page 5-volume market report is the first and most comprehensive review of the global COVID-19 Pandemic Mitigation Products & Services market available today. The objective of this report is to provide today's strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market. The report includes the industry value chain, SWOT analysis, market drives & inhibitors, business opportunities, barriers to entry, supplier power, buyer power and barriers to substitution.

The 2024 COVID-19 Pandemic Mitigation
Products Market (Scenario A), by Region

Why Buy this Homeland Security Market Report?

A. Questions answered in this report include:

  • What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecast trends during 2020-2024?
  • What are the most attractive business opportunities?
  • What drives the customers to purchase solutions and services?
  • What are the COVID-19 Mitigation technology & services trends?
  • What is the 212 sub-markets size over the 2020-2024 period?
  • What are the challenges to market penetration & growth?

B. The COVID-19 Pandemic Mitigation Products Market size data is analyzed via 5 independent key perspectives.

With a highly fragmented market we address the "money trail" - each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

By 54 Products and Services:

  • 1. Vaccines
  • 2. Therapeutic Drugs
  • 3. Other COVID-19 Pharma Industry Products
  • 4. PCR Instrumentation & Software
  • 5. Robotic PCR Systems & Software
  • 6. PCR Reagents & Consumables
  • 7. Nose & Mouth Swabs
  • 8. Self-collection PCR Test Kits
  • 9. Serologic Test Kits
  • 10. Standoff Thermometry
  • 11. X-Ray Procedures
  • 12. CT Procedures
  • 13. Ultrasound Procedures
  • 14. FDG-PET/CT Procedures & Wastewater Testing
  • 15. PACS & Teleradiology
  • 16. Medical PPE Gowns
  • 17. Medical Gloves
  • 18. Medical Face Masks
  • 19. Medical Face Shields
  • 20. Medical Eye Protection
  • 21. PPE Sterilization: Systems & Consumables
  • 22. Hand & Surface Sanitizers
  • 23. Decontamination
  • 24. Other Personal Protection Gear
  • 25. AI, Big Data & Deep Learning
  • 26. Homecare IT
  • 27. Geo-Surveillance Systems & Services
  • 28. E-Health
  • 29. Blockchain Technologies
  • 30. Other ICT
  • 31. Noninvasive Ventilators
  • 32. Invasive Mechanical Ventilators
  • 33. Next Generation Ventilators
  • 34. COVID-19 Homecare (HW, SW, Services)
  • 35. Portable Ventilators
  • 36. Surge Capacity Hospitals & ICUs
  • 37. Kidney Dialysis
  • 38. Extracorporeal Membrane Oxygenation Procedures
  • 39. Other Intensive Care Modalities
  • 40. PPE Gowns Manufacturing Plants
  • 41. Gloves Manufacturing Plants
  • 42. Face Masks Manufacturing Plants
  • 43. Face Shields Manufacturing Plants
  • 44. Sorologic Test Kits Manufacturing Plants
  • 45. Melt-Blown PPE Fabric Manufacturing Plants
  • 46. Spun-Bond PPE Fabric Manufacturing Plants
  • 47. Self-collection PCR Test Kits Manufacturing Plants
  • 48. Ventilators Manufacturing Plants
  • 49. PCR Reagents Manufacturing Plants
  • 50. PCR Systems Manufacturing Plants
  • 51. Nose & Mouth Swabs Manufacturing Plants
  • 52. Medical Glass & Other Manufacturing Plants
  • 53. R&D Equipment & Consumables
  • 54. Medical Glass and Other Products & Services

By 6 End User Markets:

  • 1. Hospitals and Surge Hospitals
  • 2. Clinical Labs
  • 3. Clinics
  • 4. Emergency Medical Services (EMS)
  • 5. Homecare & Nursing Homes
  • 6. Research Bodies

By 13 National Markets:

  • 1. U.S.A
  • 2. Canada
  • 3. UK
  • 4. Germany
  • 5. France
  • 6. Italy
  • 7. Rest of Europe
  • 8. India
  • 9. China
  • 10. South Korea
  • 11. Japan
  • 12. Rest of Asia Pacific
  • 13. RoW

By 5 Regional Markets:

  • 1. North America
  • 2. Latin America
  • 3. Europe
  • 4. Middle East & Africa
  • 5. Asia PacifiC

By 4 Revenue Source Markets:

  • 1. Product Sales
  • 2. Training Services
  • 3. Planning & Consulting
  • 4. Maintenance & Upgrade

C. Detailed market analysis frameworks for each of the market sectors are provided, including:

  • 1. Market drivers & inhibitors
  • 2. Business opportunities
  • 3. SWOT analysis

Competitive analysis for each of the 54 products and services that covers:

  • 1. Barriers to Entry
  • 2. Supplier Power
  • 3. Buyer Power
  • 4. Barriers to Substitution.
  • 5. Business environment
  • 6. The 2020-2024 market segmented into 212 submarkets

D. The report provides an updated extensive data of the leading 37 companies (including companies' profile, recent annual revenues, COVID-19 mitigation activities & products and contact information).

E. The report includes over 2300 links to the COVID-19 Pandemic Mitigation community information sources

F. The report mentions > 450 Vendors including the following:

3M Company, 3Scan, Abbott , AbCellera, Advenio Technosys, Agfa Healthcare, Agilent Technologies, AiCure, Aindra, Allscripts Healthcare Solutions, Amara Health Analytics , Amazon , analyticsMD, Apixio, Apple, Arterys Inc, Atlas Wearables, Atomwise, Avalon Nutrition VITL, Babylon Health, Bay Labs, Behold.ai, benevolent.ai, BIOBEATS, BlueDot, Bollé Safety, Bullard, Buoy Health, Care Angel Wearables QorQL, Careskore, Clinithink, Cloud Pharmaceuticals, CloudMedx, CureMetrix Mental health Ginger.io, Cyrcadia, Deep 6 AI, Deep Genomics, Dell Technologies Inc., Delta Plus Group, Desktop Genetics Virtual mate Ada Health, DreaMed Diabetes, Dupont, EaglEyeMed, Eli Lilly, Encon Safety Products, Enlitic, EnsoData, Entopsis, Envisagenics Research iCarbonX, ERB Industries Inc., Ergodyne, Essilor of America, Flashback Technologies, Flow Health, Ford, Freenome, Frequency Therapeutics Inc., Fujifilm Holdings Corporation, Gateway Safety Inc., GE Healthcare, General Electric, General Motors, General Vision, Gentex Corporation, Gibco, Gilead Sciences, Globavir Biosciences, Google, Healint, Health Fidelity, HealthNextGen, HexArmor, Hindsait, Honeywell Safety Products, IBM, Imagen Technologies, Imagia Cybernetics, Infermedica, Infervision, Inovio Pharmaceuticals, Inside DNA, InSilico Medicine, Intel Corporation, Intendu, Invitrogen, Ion Torrent, Ironwear, Johnson & Johnson (Janssen), Jvion, Kapa Biosystems, Keen Eye Technologies, Kimberly-Clark Professional, Koninklijke Philips NV, Lexmark International Inc., LifeGraph, Lucina Health, Lumiata, Lunit, Lytics, Magnea, Maxim Biotech, Maxwell MRI, McKesson Corporation, MCR Safety, Medal, Medalogix, Medasense, MedAware, Medtronic, MedWhat, MedyMatch , Merck, Metabiota, Micron Technology, Microsoft Corporation, Mindshare Medical, Moderna, Morpheo, Niramai Health Analytix, Novarad Corporation, NuMedii, Numerate, Nuritas Pharma Turbine, Nvidia Corporation, Oncora Medical, Ovuline, PeerWell, Pfizer, Philips, Philips Healthcare, PhysIQ., Precision Health Intelligence, Predible Health, Profility, Proscia, pulseData, Pyramex Safety, Qualaris Healthcare Solutions, Qualcomm Incorporated, Qualcomm Incorporated, Qure. Ai, Radians Inc., Recursion Pharmaceuticals, Regeneron Pharmaceuticals, Roam Analytics , Roche, RxPREDICT, Safety Optical Service, Samsung Electronics Co., Ltd, Sanofi, Saykara, Sellstrom Manufacturing Company (SureWerx), Sense.ly, Sensory Inc., Siemens, Sigma-Aldrich Corp., Skymind Inc., Thermo Fisher Scientific, Toshiba, Vir Biotechnology Inc., VisionAid Inc., WuXi Biologics, Xilinx Inc..

G. COVID-19 Pandemic Mitigation Products & Services Market report includes 24 appendices:

  • 1. Appendix 1: Differences & Similarities Between Common Flu and Coronavirus
  • 2. Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel
  • 3. Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection
  • 4. Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns
  • 5. Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks
  • 6. Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators
  • 7. Appendix 7: CDC Adult Vaccine Price List
  • 8. Appendix 8: The CDC COVID-19 Bio-Safety Guidelines
  • 9. Appendix 9: The 2020 Global Desperation to Protect Medical Workers
  • 10. Appendix 10: Disinfection Procedures for COVID-19
  • 11. Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020
  • 12. Appendix 12: European Preparedness Against Emerging Epidemics
  • 13. Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19
  • 14. Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization
  • 15. Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)
  • 16. Appendix 16: Comparing Clinical COVID-19 Data by Nation
  • 17. Appendix 17: Home Healthcare IT
  • 18. Appendix 18: The Difference between PCR and Antibody Tests
  • 19. Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021
  • 20. Appendix 20: COVID-19 Tests
  • 21. Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region
  • 22. Appendix 22: Abbreviations
  • 23. Appendix 23: Glossary
  • 24. Appendix 24: Bibliography

COVID-19 pandemic mitigation market research team

The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen identification, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, ultrasound, electron microscopy, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.

As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products and services industries. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies. The team published six months later a set of 32 Coronavirus mitigation market reports.

Table of Contents

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 1

1. Market Definition

  • 1.1. Introduction
  • 1.2. Scenario A: Assumptions
  • 1.3. Scenario B: Assumptions

2. Executive Summary

  • 2.1. Key Findings
  • 2.2. COVID-19 Mitigation Funding (January - May 2020)
  • 2.3. Key Conclusions
  • 2.4. COVID-19 Pandemic Mitigation Products Market Research Vectors
  • 2.5. COVID-19 Pandemic Mitigation R&D Challenges
  • 2.6. Global COVID-19 Pandemic Mitigation Market - 2020-2024
    • 2.6.1. Products & Services Groups Markets
    • 2.6.2. Products & Services Markets
    • 2.6.3. Vertical Markets
    • 2.6.4. Revenue Source Markets
    • 2.6.5. Regional Markets
    • 2.6.6. National Markets

3. The SARS CoV 2 2019 Pandemic

  • 3.1. COVID-19 Basics
  • 3.2. COVID-19 Infection Rate
  • 3.3. Social Distancing
  • 3.4. The Effect of Quarantine
  • 3.5. Comparison of SARS-CoV-2 and Common Cold and Flu Viruses
  • 3.6. The SARS-CoV-2 Genome Information
  • 3.7. Active Infection Testing
    • 3.7.1. Nucleic Acid Detection
    • 3.7.2. Antigen Detection
    • 3.7.3. Other Technologies
  • 3.8. Serology Testing

4. Market Drivers

5. Market Inhibitors

  • 6. COVID-19 Pandemic Mitigation Products Market SWOT Analysis
  • 6.1. Strengths
  • 6.2. Weaknesses
  • 6.3. Opportunities
  • 6.4. Threats

7. Business Opportunities & Challenges

8. COVID-19 Pandemic Mitigation Industry

  • 8.1. The COVID-19 Pandemic Mitigation Products Value Chain
  • 8.2. COVID-19 Pandemic Mitigation Products Industry Primary Activities
  • 8.3. COVID-19 Pandemic Mitigation Products industry Support Activities

9. COVID-19 Pandemic Mitigation Products Industry: Barriers to Entry, Supplier Power, Buyer Power & Barriers to Substitution

GLOBAL MARKET

10. Global COVID-19 Pandemic Mitigation Market - 2020-2024

  • 10.1. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets - 2020-2024
    • 10.1.1. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario A
      • 10.1.1.1. Market Size
      • 10.1.1.2. Market Dynamics
      • 10.1.1.3. Market Share
    • 10.1.2. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario B
      • 10.1.2.1. Market Size
      • 10.1.2.2. Market Dynamics
      • 10.1.2.3. Market Share
    • 10.1.3. Global COVID-19 Pandemic Mitigation Market: Scenarios Comparison
  • 10.2. Global COVID-19 Pandemic Mitigation Products & Services Markets - 2020-2024
    • 10.2.1. Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario A
      • 10.2.1.1. Market Size
      • 10.2.1.2. Market Dynamics
    • 10.2.2. Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario B
      • 10.2.2.1. Market Size
      • 10.2.2.2. Market Dynamics
    • 10.2.3. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenarios Comparison
  • 10.3. Global Vertical COVID-19 Pandemic Mitigation Markets - 2020-2024
    • 10.3.1. Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario A
      • 10.3.1.1. Market Size
      • 10.3.1.2. Market Dynamics
      • 10.3.1.3. Market Share
    • 10.3.2. Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario B
      • 10.3.2.1. Market Size
      • 10.3.2.2. Market Dynamics
      • 10.3.2.3. Market Share
    • 10.3.3. Global COVID-19 Pandemic Mitigation Vertical Markets: Scenarios Comparison
  • 10.4. Global COVID-19 Pandemic Mitigation Products & Services Market by Revenue Source - 2020-2024
    • 10.4.1. Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
    • 10.4.2. Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario B
    • 10.4.3. Global COVID-19 Pandemic Mitigation Revenue Sources: Scenarios Comparison
  • 10.5. Regional COVID-19 Pandemic Mitigation Markets - 2020-2024
    • 10.5.1. Regional COVID-19 Pandemic Mitigation Market: Scenario A
      • 10.5.1.1. Market Size
      • 10.5.1.2. Market Dynamics
      • 10.5.1.3. Market Share
    • 10.5.2. Regional COVID-19 Pandemic Mitigation Market: Scenario B
      • 10.5.2.1. Market Size
      • 10.5.2.2. Market Dynamics
      • 10.5.2.3. Market Share
    • 10.5.3. Regional COVID-19 Pandemic Mitigation Market: Scenarios Comparison
  • 10.6. National COVID-19 Pandemic Mitigation Markets - 2020-2024
    • 10.6.1. National COVID-19 Pandemic Mitigation Market: Scenario A
      • 10.6.1.1. Market Size
      • 10.6.1.2. Market Dynamics
      • 10.6.1.3. Market Shares
    • 10.6.2. National COVID-19 Pandemic Mitigation Market: Scenario B
      • 10.6.2.1. Market Size
      • 10.6.2.2. Market Dynamics
      • 10.6.2.3. Market Share
    • 10.6.3. COVID-19 National Markets: Scenarios Comparison

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 2

PRODUCT/SERVICE MARKETS

1. COVID-19 Vaccines Market - 2020-2024

  • 1.1. COVID-19 Vaccines Market Background
    • 1.1.1. Introduction
    • 1.1.2. Global COVID-19 Vaccine Development Funding
    • 1.1.3. Vaccines Prices
    • 1.1.4. COVID-19 Vaccines Market: Conclusions
    • 1.1.5. COVID-19 Vaccines:Business Opportunities
    • 1.1.6. COVID-19 Vaccines: Competitive Analysis: : Barriers to Entry, Supplier Power, Buyer Power and Substitution
    • 1.1.7. Present and Potential Vendors
  • 1.2. Global COVID-19 Pandemic Mitigation: Vaccines Market - 2020-2024
    • 1.2.1. Vaccines COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 1.2.2. Vaccines COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

2. COVID-19 Post-Infection Therapeutic Drugs Market - 2020-2024

  • 2.1. COVID-19 Post-Infection Therapies Drugs Market Background
    • 2.1.1. Introduction
    • 2.1.2. Computer Aided COVID-19 Drug Research
    • 2.1.3. Adaptive Designs For COVID 19 Clinical Trials
    • 2.1.4. COVID-19 Therapeutic Drugs Market: Conclusions
    • 2.1.5. COVID-19 Therapeutic Drug :Business Opportunities
    • 2.1.6. COVID-19 Post-Infection Therapeutic Drug: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
    • 2.1.7. Present and Potential Vendors
  • 2.2. Global COVID-19 Post-Infection Therapeutic Drugs Market - 2020-2024
    • 2.2.1. COVID-19 Post Infection Therapeutic Drugs Market - 2020-2024: Scenario A
    • 2.2.2. Therapeutic Drugs COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

3. Other Pharma Industry Products COVID-19 Pandemic Mitigation Market - 2020-2024

  • 3.1. Other COVID-19 Pharma Industry Products Market Background
    • 3.1.1. Introduction and Findings
    • 3.1.2. Other COVID-19 Pharma Industry Products Market: Conclusions
    • 3.1.3. Other COVID-19 Pharma Industry Products: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 3.2. Global COVID-19 Pandemic Mitigation: Other Pharma Industry Products Market - 2020-2024
    • 3.2.1. Other Pharma Industry Products COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 3.2.2. Other Pharma Industry Products COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

4. PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market - 2020-2024

  • 4.1. COVID-19 PCR Instrumentation & Software Market Background
    • 4.1.1. Introduction
    • 4.1.2. PCR Technologies & Procedures
    • 4.1.3. PCR Advantages
    • 4.1.4. PCR Limitations
    • 4.1.5. PCR Based Coronavirus Diagnostics Used and Developed During January - April 2020
    • 4.1.6. Efforts to Develop and Disseminate a Test for COVID-19
    • 4.1.7. PCR Purchasing Considerations
    • 4.1.8. Costs of PCR Testing
    • 4.1.9. PCR Instrumentation & Software Market: Conclusions
    • 4.1.10. PCR Instrumentation & Software: Business Opportunities
    • 4.1.11. PCR Instrumentation & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
    • 4.1.12. Key Vendors
  • 4.2. Global COVID-19 Pandemic Mitigation: PCR Instrumentation & Software Market - 2020-2024
    • 4.2.1. PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 4.2.2. PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

5. Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market - 2020-2024

  • 5.1. COVID-19 Robotic PCR Systems & Software Market Background
    • 5.1.1. Introduction and Findings
    • 5.1.2. Pooling PCR Method Testing Over 60 Samples Simultaneously
    • 5.1.3. Robotic PCR Systems & Software Market: Conclusions
    • 5.1.4. Robotic PCR Systems & Software: Business Opportunities
    • 5.1.5. Robotic PCR Systems & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 5.2. Global COVID-19 Pandemic Mitigation: Robotic PCR Systems & Software Market - 2020-2024
    • 5.2.1. Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 5.2.2. Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

6. PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

  • 6.1. COVID-19 PCR Reagents & Consumables Market Background
    • 6.1.1. Introduction
    • 6.1.2. PCR Reagents & Consumables Market: Conclusions
    • 6.1.3. PCR Reagents & Consumables: Business Opportunities
    • 6.1.4. PCR Reagents & Consumables: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 6.2. 1.2 Global COVID-19 Pandemic Mitigation: PCR Reagents & Consumables Market - 2020-2024
    • 6.2.1. PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 6.2.2. PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

7. Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market - 2020-2024

  • 7.1. COVID-19 Nose & Mouth Swabs Market Background
    • 7.1.1. Introduction and Findings
    • 7.1.2. Nose & Mouth Swabs: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 7.2. Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Market - 2020-2024
    • 7.2.1. Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 7.2.2. Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

8. Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024

  • 8.1. COVID-19 Self-collection PCR Test Kits Market Background
    • 8.1.1. Saliva Tests
  • 8.2. COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Market - 2020-2024
    • 8.2.1. Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 8.2.2. Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

9. Serologic Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024

  • 9.1. COVID-19 Serologic Test Kits Market Background
    • 9.1.1. Introduction and Findings
    • 9.1.2. FDA Statement Related to the Status of Serological (Antibody) Tests
    • 9.1.3. Coronavirus Antibody Test Kits
    • 9.1.4. Serologic Test Kits Market: Conclusions
    • 9.1.5. Serologic Test Kits: Business Opportunities
    • 9.1.6. Serologic Test Kits: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
    • 9.1.7. Key Vendors
  • 9.2. Global COVID-19 Pandemic Mitigation: Serologic Test Kits Market - 2020-2024
    • 9.2.1. Serologic Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 9.2.2. Serologic Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

10. Standoff Thermometry COVID-19 Pandemic Mitigation Market - 2020-2024

  • 10.1. COVID-19 Standoff Thermometry Market Background
    • 10.1.1. Introduction and Findings
    • 10.1.2. Standoff Thermometry Market: Conclusions
    • 10.1.3. Standoff Thermometry: Business Opportunities
    • 10.1.4. Key Vendors
  • 10.2. Global COVID-19 Pandemic Mitigation: Standoff Thermometry Market - 2020-2024
    • 10.2.1. Standoff Thermometry COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 10.2.2. Standoff Thermometry COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

11. X-Ray Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

  • 11.1. COVID-19 X-Ray Procedures Market Background
    • 11.1.1. Introduction and Findings
    • 11.1.2. X-Ray Procedures Market: Conclusions
    • 11.1.3. Key Vendors
  • 11.2. Global COVID-19 Pandemic Mitigation: X-Ray Procedures Market - 2020-2024
    • 11.2.1. X-Ray Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 11.2.2. X-Ray Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

12. CT Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

  • 12.1. COVID-19 CT Procedures Market Background
    • 12.1.1. Introduction and Findings
    • 12.1.2. CT Procedures Market: Conclusions
    • 12.1.3. CT Procedures: Business Opportunities
    • 12.1.4. Key Vendors
  • 12.2. Global COVID-19 Pandemic Mitigation: CT Procedures Market - 2020-2024
    • 12.2.1. CT Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 12.2.2. CT Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

13. Ultrasound Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

  • 13.1. COVID-19 Ultrasound Procedures Market Background
    • 13.1.1. Introduction and Findings
    • 13.1.2. FDA Approved " EMT & Field" Smartphone-Tablet Based Coronavirus Chest Ultrasound
    • 13.1.3. COVID-19 Chest Ultrasound Diagnostics
    • 13.1.4. Ultrasound Procedures Market: Conclusions
    • 13.1.5. Ultrasound Procedures: Business Opportunities
    • 13.1.6. Key Vendors
  • 13.2. Global COVID-19 Pandemic Mitigation: Ultrasound Procedures Market - 2020-2024
    • 13.2.1. Ultrasound Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 13.2.2. Ultrasound Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

14. FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market - 2020-2024

  • 14.1. COVID-19 FDG-PET/CT Procedures & Wastewater Testing Market Background
    • 14.1.1. Introduction and Findings
    • 14.1.2. FDG-PET/CT Procedures
    • 14.1.3. COVID-19 Wastewater Testing
    • 14.1.4. FDG-PET/CT Procedures & Wastewater Testing Market: Conclusions
    • 14.1.5. FDG-PET/CT Procedures & Wastewater Testing: Business Opportunities
    • 14.1.6. Key Vendors
  • 14.2. Global COVID-19 Pandemic Mitigation: FDG-PET/CT Procedures & Wastewater Testing Market - 2020-2024
    • 14.2.1. FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 14.2.2. FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

15. PACS & Teleradiology COVID-19 Pandemic Mitigation Market - 2020-2024

  • 15.1. PACS & Teleradiology Market Background
    • 15.1.1. Introduction and Findings
    • 15.1.2. The FDA PACS & Teleradiography COVID-19 Pandemic Policy
    • 15.1.3. PACS & Teleradiology Market: Conclusions
    • 15.1.4. PACS & Teleradiology: Business Opportunities
    • 15.1.5. Key Vendors
  • 15.2. Global COVID-19 Pandemic Mitigation: PACS & TeleradiologyMarket - 2020-2024
    • 15.2.1. PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 15.2.2. PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

16. PPE Gowns COVID-19 Pandemic Mitigation Market - 2020-2024

  • 16.1. Pandemic PPE Gowns Market Background
    • 16.1.1. Introduction and Findings
    • 16.1.2. PPE Gowns Market: Conclusions
    • 16.1.3. PPE Gowns: Business Opportunities
  • 16.2. Global COVID-19 Pandemic Mitigation: PPE Gowns Market - 2020-2024
    • 16.2.1. PPE Gowns COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 16.2.2. PPE Gowns COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

17. Gloves COVID-19 Pandemic Mitigation Market - 2020-2024

  • 17.1. COVID-19 Gloves Market Background
    • 17.1.1. Introduction and Findings
    • 17.1.2. Gloves Market: Conclusions
    • 17.1.3. Gloves: Business Opportunities
  • 17.2. Global COVID-19 Pandemic Mitigation: Gloves Market - 2020-2024
    • 17.2.1. Gloves COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 17.2.2. Gloves COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

18. Face Masks COVID-19 Pandemic Mitigation Market - 2020-2024

  • 18.1. Medical Face Masks Market Background
    • 18.1.1. Introduction and Findings
    • 18.1.2. N95 Masks Vs. Surgical Mask
    • 18.1.3. Face Masks Precautions
    • 18.1.4. Face Masks Market: Conclusions
    • 18.1.5. Face Masks: Business Opportunities
    • 18.1.6. Key Vendors
  • 18.2. Global COVID-19 Pandemic Mitigation: Face Masks Market - 2020-2024
    • 18.2.1. Face Masks COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 18.2.2. Face Masks COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

19. Medical Face Shields COVID-19 Pandemic Mitigation Market - 2020-2024

  • 19.1. Medical Face Shields Market Background
    • 19.1.1. Introduction and Findings
    • 19.1.2. Face Shields Standards
  • 19.2. Global COVID-19 Pandemic Mitigation: Medical Face Shields Market - 2020-2024
    • 19.2.1. Medical Face Shields COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 19.2.2. Medical Face Shields COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

20. Eye Protection COVID-19 Pandemic Mitigation Market - 2020-2024

  • 20.1. Pandemic Eye Protection Market Background
    • 20.1.1. Introduction and Findings
    • 20.1.2. Key Vendors
  • 20.2. Global COVID-19 Pandemic Mitigation: Eye Protection Market - 2020-2024
    • 20.2.1. Eye Protection COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 20.2.2. Eye Protection COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

21. PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

  • 21.1. Global COVID-19 Pandemic Mitigation: PPE Sterilization: Systems & Consumables Market - 2020-2024
    • 21.1.1. PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 21.1.2. PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

22. Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market - 2020-2024

  • 22.1. Hand & Surface Sanitizers Market Background
  • 22.2. Global COVID-19 Pandemic Mitigation: Hand & Surface Sanitizers Market - 2020-2024
    • 22.2.1. Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 22.2.2. Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

23. Decontamination COVID-19 Pandemic Mitigation Market - 2020-2024

  • 23.1. Decontamination Market Background
    • 23.1.1. Introduction
    • 23.1.2. Definitions
    • 23.1.3. Timing and Location Of Cleaning And Disinfection Of Surfaces
    • 23.1.4. Hard (Non-porous) Surfaces
    • 23.1.5. Soft (Porous) Surfaces
    • 23.1.6. Electronics
    • 23.1.7. Linens, Clothing, and Other Items That Go in the Laundry
    • 23.1.8. Risk of Exposure
    • 23.1.9. Considerations for Employers
    • 23.1.10. Decontamination Market: Conclusions
  • 23.2. Global COVID-19 Pandemic Mitigation: Decontamination Market - 2020-2024
    • 23.2.1. Decontamination COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 23.2.2. Decontamination COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

24. Other Personal Protection Gear COVID-19 Pandemic Mitigation Market - 2020-2024

  • 24.1. Global COVID-19 Pandemic Mitigation: Other Personal Protection Gear Market - 2020-2024
    • 24.1.1. Other Personal Protection Gear COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 24.1.2. Other Personal Protection Gear COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

25. AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market - 2020-2024

  • 25.1. Pandemic AI, Big Data & Deep Learning Market Background
    • 25.1.1. Introduction and Findings
    • 25.1.2. AI Based Early Warnings and Alerts
    • 25.1.3. Tracking and Prediction
    • 25.1.4. Data Dashboards
    • 25.1.5. Diagnosis and Prognosis
    • 25.1.6. COVID-19 Treatments Optimization
    • 25.1.7. COVID-19 Pandemic Social Control
    • 25.1.8. Pandemic Outbreak Forecasting
    • 25.1.9. AI, Big-Data and Deep Learning Assisted CT Imaging
    • 25.1.10. AI, Big-Data and Deep-Learning Assisted COVID-19 Treatment
    • 25.1.11. COVID-19: AI Assisted X-rays Imaging
    • 25.1.12. COVID-19 AI, Big Data & Deep Learning
    • 25.1.13. AI Assisted Pandemic Symptoms Analysis
    • 25.1.14. AI, Big Data & Deep Learning Market: Conclusions
    • 25.1.15. AI, Big Data & Deep Learning: Business Opportunities
    • 25.1.16. Key Vendors
  • 25.2. Global COVID-19 Pandemic Mitigation: AI, Big Data & Deep Learning Market - 2020-2024
    • 25.2.1. AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 25.2.2. AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

26. Homecare IT COVID-19 Pandemic Mitigation Market - 2020-2024

  • 26.1. Pandemic Homecare IT Market Background
    • 26.1.1. Introduction and Findings
    • 26.1.2. Homecare IT Market: Conclusions
    • 26.1.3. Homecare IT: Business Opportunities
    • 26.1.4. Key Vendors
  • 26.2. Global COVID-19 Pandemic Mitigation: Homecare IT Market - 2020-2024
    • 26.2.1. Homecare IT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 26.2.2. Homecare IT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

27. Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market - 2020-2024

  • 27.1. Pandemic Geo-Surveillance Systems & Services Market Background
    • 27.1.1. Introduction and Findings
    • 27.1.2. MIT "Private Kit"
    • 27.1.3. The UK NHS COVID-19 App
    • 27.1.4. Companies Making Cell Location Tracking Technology
  • 27.2. Global COVID-19 Pandemic Mitigation: Geo-Surveillance Systems & Services Market - 2020-2024
    • 27.2.1. Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 27.2.2. Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

28. E-Health COVID-19 Pandemic Mitigation Market - 2020-2024

  • 28.1. Pandemic E-Health Market Background
    • 28.1.1. Introduction and Findings
    • 28.1.2. E-Health Market: Conclusions
    • 28.1.3. E-Health: Business Opportunities
    • 28.1.4. Key Vendors
  • 28.2. Global COVID-19 Pandemic Mitigation: E-Health Market - 2020-2024
    • 28.2.1. E-Health COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 28.2.2. E-Health COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

29. Blockchain Technologies COVID-19 Pandemic Mitigation Market - 2020-2024

  • 29.1. Pandemic Blockchain Technologies Market Background
    • 29.1.1. Introduction and Findings
    • 29.1.2. Blockchain in Healthcare
    • 29.1.3. Blockchain Applications
    • 29.1.4. Blockchain Technologies Market: Conclusions
    • 29.1.5. Blockchain Technologies: Business Opportunities
    • 29.1.6. Key Vendors
  • 29.2. Global COVID-19 Pandemic Mitigation: Blockchain Technologies Market - 2020-2024
    • 29.2.1. Blockchain Technologies COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 29.2.2. Blockchain Technologies COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

30. Other ICT COVID-19 Pandemic Mitigation Market - 2020-2024

  • 30.1. Other Pandemics ICT Market Background
    • 30.1.1. Introduction and Findings
    • 30.1.2. Other ICT Market: Conclusions
    • 30.1.3. Other ICT: Business Opportunities
    • 30.1.4. Vendors
  • 30.2. Global COVID-19 Pandemic Mitigation: Other ICT Market - 2020-2024
    • 30.2.1. Other ICT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 30.2.2. Other ICT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

31. Noninvasive Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

  • 31.1. Non-Invasive Ventilators Market Background
    • 31.1.1. Introduction and Findings
    • 31.1.2. The U.S. HHS Procurement Contracts On Non-Invasive Ventilators With Ten Vendors
    • 31.1.3. Helmet-Based Non-invasive Ventilators
    • 31.1.4. Non-invasive Ventilators Market: Conclusions
    • 31.1.5. Business Opportunities
    • 31.1.6. Non-invasive Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
    • 31.1.7. Key Vendors
  • 31.2. Global COVID-19 Pandemic Mitigation: Noninvasive Ventilators Market - 2020-2024
    • 31.2.1. Noninvasive Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 31.2.2. Noninvasive Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

32. Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

  • 32.1. Invasive Mechanical Ventilators Market Background
    • 32.1.1. Introduction and Findings
    • 32.1.2. Challenges of Traditional Mechanical Ventilation Devices
      • 32.1.2.1. Difficult To Expand Capacity And Limited Portability
      • 32.1.2.2. Complex and Time Consuming To Administer Care
      • 32.1.2.3. Difficult To Switch Between Therapies
    • 32.1.3. Invasive Mechanical Ventilators Market: Conclusions
    • 32.1.4. Invasive Mechanical Ventilators: Business Opportunities
    • 32.1.5. Invasive Mechanical Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
    • 32.1.6. Key Vendors
  • 32.2. Global COVID-19 Pandemic Mitigation: Invasive Mechanical Ventilators Market - 2020-2024
    • 32.2.1. Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 32.2.2. Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

33. Next Generation Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

  • 33.1. Next Generation Ventilators Market Background
    • 33.1.1. Introduction and Findings
    • 33.1.2. Next Generation Ventilators Market: Conclusions
    • 33.1.3. Next Generation Ventilators: Business Opportunities
    • 33.1.4. Next Generation Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
  • 33.2. Global COVID-19 Pandemic Mitigation: Next Generation Ventilators Market - 2020-2024
    • 33.2.1. Next Generation Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 33.2.2. Next Generation Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

34. Homecare "ICU" (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market - 2020-2024

  • 34.1. COVID-19 Homecare "ICU" (Equipment, Software, Services) Market Background
    • 34.1.1. Introduction and Findings
    • 34.1.2. WHO Protocol For COVID-19 Homecare
    • 34.1.3. Homecare Market: Conclusions
    • 34.1.4. Homecare Business Opportunities
    • 34.1.5. Homecare: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
    • 34.1.6. Key Vendors
  • 34.2. Global COVID-19 Pandemic Mitigation: Homecare "ICU" (Equipment, Software, Services) Market - 2020-2024
    • 34.2.1. Homecare "ICU" (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 34.2.2. Homecare "ICU" (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B
  • 34.3. Portable Ventilators Market Background
    • 34.3.1. Introduction and Findings
    • 34.3.2. Portable Ventilators Market: Conclusions
    • 34.3.3. Key Vendors
  • 34.4. Global COVID-19 Pandemic Mitigation: Mobile Ventilators Market - 2020-2024
    • 34.4.1. Mobile Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 34.4.2. Mobile Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

35. Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024

  • 35.1. Surge Capacity Hospitals Market Background
    • 35.1.1. Introduction and Findings
    • 35.1.2. Surge Capacity Hospitals Market: Conclusions
  • 35.2. Global COVID-19 Pandemic Mitigation: Surge Capacity Hospitals Market - 2020-2024
    • 35.2.1. Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 35.2.2. Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

36. Kidney Dialysis COVID-19 Pandemic Mitigation Market - 2020-2024

  • 36.1. Kidney Dialysis Systems Market Background
    • 36.1.1. Introduction and Findings
    • 36.1.2. Kidney Dialysis Systems Market: Conclusions
    • 36.1.3. Kidney Dialysis Systems: Business Opportunities
    • 36.1.4. Key Vendors
  • 36.2. Global COVID-19 Pandemic Mitigation: Kidney Dialysis Market - 2020-2024
    • 36.2.1. Kidney DialysisCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 36.2.2. Kidney DialysisCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

37. Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

  • 37.1. Extracorporeal Membrane Oxygenation Procedures Market Background
    • 37.1.1. Introduction and Findings
    • 37.1.2. The FDA Extracorporeal Membrane Oxygenation (ECMO) Policy
    • 37.1.3. Extracorporeal Membrane Oxygenation Procedures Market: Conclusions
    • 37.1.4. Extracorporeal Membrane Oxygenation Procedures: Business Opportunities
    • 37.1.5. Key Vendors
  • 37.2. Global COVID-19 Pandemic Mitigation: Extracorporeal Membrane Oxygenation Procedures Market - 2020-2024
    • 37.2.1. Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 37.2.2. Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

38. Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market - 2020-2024

  • 38.1. Other Intensive Care Modalities Market Background
    • 38.1.1. Introduction and Findings
    • 38.1.2. Other Intensive Care Modalities Market: Conclusions
  • 38.2. Global COVID-19 Pandemic Mitigation: Other Intensive Care Modalities Market - 2020-2024
    • 38.2.1. Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 38.2.2. Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

39. Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 39.1. PPE Gowns Manufacturing Plants Market Background
    • 39.1.1. Introduction and Findings
    • 39.1.2. Gowns Manufacturing Plants Market: Conclusions
    • 39.1.3. Gowns Manufacturing Plants: Business Opportunities
  • 39.2. Global COVID-19 Pandemic Mitigation: Gowns Manufacturing Plants Market - 2020-2024
    • 39.2.1. Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 39.2.2. Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

40. Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 40.1. Medical PPE Gloves Manufacturing Plants Market Background
    • 40.1.1. Introduction and Findings
    • 40.1.2. Medical PPE Gloves Manufacturing Plants Market: Conclusions
    • 40.1.3. Medical PPE Gloves Manufacturing Plants: Business Opportunities
  • 40.2. Global COVID-19 Pandemic Mitigation: Gloves Manufacturing Plants Market - 2020-2024
    • 40.2.1. Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 40.2.2. Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

41. Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 41.1. Face Masks Manufacturing Plants Market Background
    • 41.1.1. Introduction and Findings
    • 41.1.2. N95 Respirators Manufacturing
    • 41.1.3. Face Masks Manufacturing Plants Market: Conclusions
    • 41.1.4. Face Masks Manufacturing Plants: Business Opportunities
    • 41.1.5. Key Vendors
  • 41.2. Global COVID-19 Pandemic Mitigation: Face Masks Manufacturing Plants Market - 2020-2024
    • 41.2.1. Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 41.2.2. Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

42. Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 42.1. Face Shields Manufacturing Plants Market Background
    • 42.1.1. Introduction and Findings
  • 42.2. Global COVID-19 Pandemic Mitigation: Face Shields Manufacturing Plants Market - 2020-2024
    • 42.2.1. Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 42.2.2. Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

43. Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 43.1. Serologic Test Kits Manufacturing Plants Market Background
    • 43.1.1. Introduction and Findings
    • 43.1.2. Serologic Test Kits Manufacturing Plants Market: Conclusions
  • 43.2. Global COVID-19 Pandemic Mitigation: Serologic Test Kits Manufacturing Plants Market - 2020-2024
    • 43.2.1. Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 43.2.2. Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

44. Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 44.1. Melt-Blown PPE Fabric Manufacturing Plants Market Background
    • 44.1.1. Introduction and Findings
    • 44.1.2. Melt-Blown PPE Fabric. Manufacturing Plants Market: Conclusions
  • 44.2. Global COVID-19 Pandemic Mitigation: Melt-Blown PPE Fabric Manufacturing Plants Market - 2020-2024
    • 44.2.1. Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 44.2.2. Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

45. Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 45.1. Spun-Bond PPE Fabric Manufacturing Plants Market Background
    • 45.1.1. Introduction and Findings
    • 45.1.2. Spun-Bond PPE Fabric Manufacturing Plants Market: Conclusions
  • 45.2. Global COVID-19 Pandemic Mitigation: Spun-Bond PPE Fabric Manufacturing Plants Market - 2020-2024
    • 45.2.1. Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 45.2.2. Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

46. Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 46.1. Market Background
  • 46.2. Global COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Manufacturing Plants Market - 2020-2024
    • 46.2.1. Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 46.2.2. Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

47. Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 47.1. Ventilators Manufacturing Plants Market Background
    • 47.1.1. Introduction and Findings
    • 47.1.2. Ventilators Manufacturing Plants Market: Conclusions
  • 47.2. Global COVID-19 Pandemic Mitigation: Ventilators Manufacturing Plants Market - 2020-2024
    • 47.2.1. Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 47.2.2. Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

48. PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 48.1. Global COVID-19 Pandemic Mitigation: PCR Reagents Manufacturing Plants Market - 2020-2024
    • 48.1.1. PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 48.1.2. PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

49. PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 49.1. Global COVID-19 Pandemic Mitigation: PCR Systems Manufacturing Plants Market - 2020-2024
    • 49.1.1. PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 49.1.2. PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

50. Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 50.1. Nose & Mouth Swabs Manufacturing Plants Market Background
    • 50.1.1. Introduction and Findings
    • 50.1.2. Swabs Manufacturing Plants Market: Conclusions
    • 50.1.3. Swabs Manufacturing Plants: Business Opportunities
  • 50.2. Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Manufacturing Plants Market - 2020-2024
    • 50.2.1. Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 50.2.2. Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

51. Medical Glass & Other Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

  • 51.1. Global COVID-19 Pandemic Mitigation: Medical Glass & Other Manufacturing Plants Market - 2020-2024
    • 51.1.1. Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 51.1.2. Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

52. R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

  • 52.1. Global COVID-19 Pandemic Mitigation: R&D Equipment & Consumables Market - 2020-2024
    • 52.1.1. R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 52.1.2. R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

53. Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market - 2020-2024

  • 53.1. Medical Glass and Other Products & Services Market Background
    • 53.1.1. Medical Glass Introduction and Findings
    • 53.1.2. Medical Glass Market: Conclusions
    • 53.1.3. Key Medical Glass Vendors
  • 53.2. Global COVID-19 Pandemic Mitigation: Medical Glass and Other Products & Services Market - 2020-2024
    • 53.2.1. Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
    • 53.2.2. Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 3

VERTICAL MARKETS

1. Hospitals and Surge Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024

  • 1.1. Market Background
  • 1.2. Global COVID-19 Pandemic Mitigation: Hospitals and Surge Hospitals Market - 2020-2024
    • 1.2.1. COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario A
    • 1.2.2. COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario B
    • 1.2.3. Hospitals and Surge Hospitals Market: Scenarios Comparison

2. Clinical Labs COVID-19 Pandemic Mitigation Market - 2020-2024

  • 2.1. Market Background
  • 2.2. Global COVID-19 Pandemic Mitigation: Clinical Labs Market - 2020-2024
    • 2.2.1. COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario A
    • 2.2.2. COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario B
    • 2.2.3. Clinical Labs Market: Scenarios Comparison

3. Clinics COVID-19 Pandemic Mitigation Market - 2020-2024

  • 3.1. Market Background
  • 3.2. Global COVID-19 Pandemic Mitigation: Clinics Market - 2020-2024
    • 3.2.1. COVID-19 Pandemic Mitigation Clinics Market: Scenario A
    • 3.2.2. COVID-19 Pandemic Mitigation Clinics Market: Scenario B
    • 3.2.3. Clinics Market: Scenarios Comparison

4. Emergency Medical Services (EMS) COVID-19 Pandemic Mitigation Market - 2020-2024

  • 4.1. Market Background
  • 4.2. Global COVID-19 Pandemic Mitigation: Emergency Medical Services (EMS) Market - 2020-2024
    • 4.2.1. COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario A
    • 4.2.2. COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario B
    • 4.2.3. Emergency Medical Services Market: Scenarios Comparison

5. Homecare & Nursing Homes COVID-19 Pandemic Mitigation Market - 2020-2024

  • 5.1. Market Background
  • 5.2. Global COVID-19 Pandemic Mitigation: Homecare & Nursing Homes Market - 2020-2024
    • 5.2.1. COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario A
    • 5.2.2. COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario B
    • 5.2.3. Homecare & Nursing Homes Market: Scenarios Comparison

6. Research Bodies COVID-19 Pandemic Mitigation Market - 2020-2024

  • 6.1. Market Background
  • 6.2. Global COVID-19 Pandemic Mitigation: Research Bodies Market - 2020-2024
    • 6.2.1. COVID-19 Pandemic Mitigation Research Bodies Market: Scenario A
    • 6.2.2. COVID-19 Pandemic Mitigation Research Bodies Market: Scenario B
    • 6.2.3. Research Bodies Market: Scenarios Comparison

REGIONAL MARKETS

7. North America COVID-19 Pandemic Mitigation Market - 2020-2024

  • 7.1. North America Vertical Markets - 2020-2024
    • 7.1.1. North America COVID-19 Pandemic Mitigation Market: Scenario A
    • 7.1.2. North America COVID-19 Pandemic Mitigation Market: Scenario B
    • 7.1.3. Scenarios Comparison
  • 7.2. North America COVID-19 Pandemic Mitigation Market by Revenue Source - 2020-2024
    • 7.2.1. North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
    • 7.2.2. North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

8. Europe COVID-19 Pandemic Mitigation Market - 2020-2024

  • 8.1. Europe Vertical Markets - 2020-2024
    • 8.1.1. Europe COVID-19 Pandemic Mitigation Market: Scenario A
    • 8.1.2. Europe COVID-19 Pandemic Mitigation Market: Scenario B
    • 8.1.3. Scenarios Comparison
  • 8.2. Europe COVID-19 Market by Revenue Source - 2020-2024
    • 8.2.1. Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
    • 8.2.2. Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

9. Asia-Pacific COVID-19 Pandemic Mitigation Market - 2020-2024

  • 9.1. Asia-Pacific Vertical Markets - 2020-2024
    • 9.1.1. Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario A
    • 9.1.2. Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario B
    • 9.1.3. Scenarios Comparison
  • 9.2. Asia-Pacific COVID-19 Market by Revenue Source - 2020-2024
    • 9.2.1. Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
    • 9.2.2. Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

10. MEA & Latin America COVID-19 Pandemic Mitigation Market - 2020-2024

  • 10.1. MEA & Latin America Vertical Markets - 2020-2024
    • 10.1.1. MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario A
    • 10.1.2. MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario B
    • 10.1.3. Scenarios Comparison
  • 10.2. MEA & Latin America COVID-19 Market by Revenue Source - 2020-2024
    • 10.2.1. MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
    • 10.2.2. MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

NATIONAL MARKETS

11. USA COVID-19 Pandemic Mitigation Market - 2020-2024

  • 11.1. Market Background
  • 11.2. USA COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

12. Canada COVID-19 Pandemic Mitigation Market - 2020-2024

  • 12.1. Market Background
  • 12.2. Canada COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

13. U.K. COVID-19 Pandemic Mitigation Market - 2020-2024

  • 13.1. Market Background
  • 13.2. U.K. COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

14. Germany COVID-19 Pandemic Mitigation Market - 2020-2024

  • 14.1. Market Background
  • 14.2. Germany COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

15. France COVID-19 Pandemic Mitigation Market - 2020-2024

  • 15.1. Market Background
  • 15.2. France COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

16. Italy COVID-19 Pandemic Mitigation Market - 2020-2024

  • 16.1. Market Background
  • 16.2. Italy COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

17. Rest of Europe COVID-19 Pandemic Mitigation Market - 2020-2024

18. India COVID-19 Pandemic Mitigation Market - 2020-2024

  • 18.1. Market Background
  • 18.2. India COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

19. China COVID-19 Pandemic Mitigation Market - 2020-2024

  • 19.1. Market Background
  • 19.2. China COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

20. South Korea COVID-19 Pandemic Mitigation Market - 2020-2024

  • 20.1. Market Background
  • 20.2. South Korea COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

21. Japan COVID-19 Pandemic Mitigation Market - 2020-2024

  • 21.1. Market Background
  • 21.2. Japan COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

22. Rest of Asia-Pacific COVID-19 Pandemic Mitigation Market - 2020-2024

23. ROW COVID-19 Pandemic Mitigation Market - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 4

APPENDICES

1. Appendix 1: Differences & Similarities Between Common Flu and Coronavirus

  • 1.1. Similarities:
  • 1.2. Differences

2. Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel

  • 2.1. Introduction
  • 2.2. Conclusions
  • 2.3. Findings Summary
  • 2.4. Background
    • 2.4.1. Description of the Condition
    • 2.4.2. Description of the Intervention
    • 2.4.3. How the Intervention Might Work
    • 2.4.4. Why it Is Important To Do This Review
    • 2.4.5. Summary

3. Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection

  • 3.1. Introduction
    • 3.1.1 Contingency Capacity Strategies
    • 3.1.2. Extended Use Of Eye Protection
    • 3.1.3. Crisis Capacity Strategies
    • 3.1.4. Selected Options for Reprocessing Eye Protection

4. Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns

  • 4.1. Purpose
  • 4.2. Conventional Capacity Strategies
  • 4.3. Contingency Capacity Strategies
  • 4.4. Crisis Capacity Strategies
  • 4.5. Extended Use of Isolation Gowns
    • 4.5.1. Re-use of Cloth Isolation Gowns
    • 4.5.2. Prioritize Gowns
    • 4.5.3. When No Gowns Are Available

5. Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks

  • 5.1. Purpose
  • 5.2. Conventional Capacity Strategies
  • 5.3. Contingency Capacity Strategies
  • 5.4. When No Facemasks Are Available, Options Include

6. Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators

7. Appendix 7: CDC Adult Vaccine Price List

  • 7.1. CDC Vaccine 2020-2021 Price List
  • 7.2. CDC Influenza Vaccine 2020-2021 Price List

8. Appendix 8: The CDC COVID-19 Bio-Safety Guidelines

  • 8.1. The CDC Safety Practices for Critical Infrastructure Workers Exposed to a Person with Suspected or Confirmed COVID-19
  • 8.2. Use of Cloth Face Coverings
  • 8.3. The Emergency Medical Services Guidance
  • 8.4. Recommendations for 911 PSAPs
    • 8.4.1. Modified Caller Queries
  • 8.5. EMS Clinicians and Medical First Responders
    • 8.5.1. Patient assessment
  • 8.6. Recommended Personal Protective Equipment
  • 8.7. Precautions for Aerosol-Generating Procedures
  • 8.8. EMS Transport of a PUI or Patient with Confirmed COVID-19 to a Healthcare Facility
  • 8.9. Documentation Of Patient Care
  • 8.10. Cleaning EMS Transport Vehicles after Transporting a PUI or Patient with Confirmed COVID-19
  • 8.11. Measures by EMS Clinicians After Caring for a PUI or Patient with Confirmed COVID-19
  • 8.12. EMS Employer Responsibilities

9. Appendix 9: The 2020 Global Desperation to Protect Medical Workers

10. Appendix 10: Disinfection Procedures for COVID-19

  • 10.1. Disinfection for Floor and Walls
  • 10.2. Disinfection of Object Surfaces
  • 10.3. Air Disinfection
  • 10.4. Disposal of Fecal Matter and Sewage
  • 10.5. Disposal Procedures for Spills of COVID-19 Patient Blood/Fluids

11. Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020

  • 11.1. Public Health and Social Services Emergency Fund - March 2020
  • 11.2. For Advance Construction, Manufacture, And Purchase Of Vaccines And Therapeutic Delivery
  • 11.3. Telehealth, Poison Control Centers, And The Ryan White HIV/AIDS Program
  • 11.4. National Institutes of Health
  • 11.5. Substance Abuse and Mental Health Services Administration
  • 11.6. Administration for Children and Families
  • 11.7. Veterans Health Administration

12. Appendix 12: European Preparedness Against Emerging Epidemics

13. Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19

  • 13.1. Introduction
  • 13.2. Diagnostic Tests
    • 13.1.1. IVD Tests
    • 13.1.2. LDT Tests
    • 13.1.3. How are IVD Tests Regulated?
    • 13.1.4. How are LDTs Regulated?
    • 13.1.5. What is CLIA and How Is It Involved in LDT Regulation?
    • 13.1.6. How are IVDs Regulated by the FDA During an Emergency Such as the Outbreak of COVID-19?
    • 13.1.7. How Does the Emergency Use Authority Apply to LDTs if They Are Generally Exempted from Premarket Requirements?
    • 13.1.8. How Does the CDC's COVID-19 Diagnostic Test Work?
    • 13.1.9. What Type of IVD is the CDC's Test and Who May Carry it Out?
    • 13.1.10. What Is the Role of the Commercial Manufacturer IDT in the Development and Distribution of the CDC's Test Kit?
    • 13.1.11. What Quality Problems Did the CDC's Test Experience on Rollout to the State and Local Public Health Laboratories?
    • 13.1.12. What Steps did the FDA Take to Expand Testing Capacity in Response to the Problems with the CDC's Test?

14. Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

15. Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)

16. Appendix 16: Comparing Clinical COVID-19 Data by Nation

  • 16.1. Introduction
  • 16.2. Counting Deaths Protocols
  • 16.3. National Death Rates
  • 16.4. National Political Factors
  • 16.5. National Testing Protocols
  • 16.6. Conclusions: Comparisons are Difficult

17. Appendix 17: Home Healthcare IT

  • 17.1. Introduction
  • 17.2. Online Bots
  • 17.3. Home Telehealth
  • 17.4. Telemedicine Billing
  • 17.5. Commercial Insurance

18. Appendix 18: The Difference between PCR and Antibody Tests

19. Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021

  • 19.1. Introduction
  • 19.2. Economic Effects
  • 19.3. USA
  • 19.4. Europe
  • 19.5. The UK
  • 19.6. Japan
  • 19.7. China
  • 19.8. The IMF
  • 19.9. The World Bank
  • 19.10 Emerging Markets
  • 19.11 Other Sectors

20. Appendix 20: COVID-19 Tests

  • 20.1. COVID-19 Tests Sensitivity and Specificity
  • 20.2. RT-PCR tests
  • 20.3. Antibody Tests
  • 20.4. Other Diagnostic Options
  • 20.5. Procurement of Test Kits and Consumables
  • 20.6. Annex A: Test Kit Options from WHO Diagnostics Consortium

21. Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region

22. Appendix 22: Abbreviations

23. Appendix 23: Glossary

24. Appendix 24: Bibliography

25. Research Methodology

  • 25.1. Scope
  • 25.2. Research Methodology

26. Disclaimer & Copyright

List of Tables

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 1

  • Table 1 - COVID-19 June 1, 2020 COVID-19 Cases and the Number Dead per Million by Country
  • Table 2 - Global Products & Services Groups Markets' Size [$M]: Scenario A - 2020-2024
  • Table 3 - Global Products & Services Groups Markets' Size [$M]: Scenario B - 2020-2024
  • Table 4 - Global Products & Services Markets' Size [$M]: Scenario A - 2020-2024
  • Table 5 - Global Products & Services Markets' Size [$M]: Scenario B - 2020-2024
  • Table 6 - Global Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Table 7 - Global Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Table 8 - Global Market Size by Revenue Source [$M] Scenario A - 2020-2024
  • Table 9 - Global Market Size by Revenue Source [$M] Scenario B - 2020-2024
  • Table 10 - Regional Markets Size [$M]: Scenario A - 2020-2024
  • Table 11 - Regional Markets Size [$M]: Scenario B - 2020-2024
  • Table 12 - National Markets Size [$M]: Scenario A - 2020-2024
  • Table 13 - National Markets Size [$M]: Scenario B - 2020-2024
  • Table 14 - COVID-19 Pandemic Mitigation Products Market: Business Opportunities
  • Table 15 - Global Products & Services Groups Markets' Size [$M]: Scenario A - 2020-2024
  • Table 16 - Global Products & Services Groups Markets' Dynamics [%]: Scenario A - 2020-2024
  • Table 17 - Global Products & Services Groups Markets' Size [$M]: Scenario B - 2020-2024
  • Table 18 - Global Products & Services Groups Markets' Dynamics [%]: Scenario B - 2020-2024
  • Table 19 - Global Products & Services Markets' Size [$M]: Scenario A - 2020-2024
  • Table 20 - Global Products & Services Markets' Dynamics [%]: Scenario A - 2020-2024
  • Table 21 - Global Products & Services Markets' Size [$M]: Scenario B - 2020-2024
  • Table 22 - Global Products & Services Markets' Dynamics [%]: Scenario B - 2020-2024
  • Table 23 - Global Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Table 24 - Global Vertical Markets' Dynamics [%]: Scenario A - 2020-2024
  • Table 25 - Global Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Table 26 - Global Vertical Markets' Dynamics [%]: Scenario B - 2020-2024
  • Table 27 - Global Market Size by Revenue Source [$M] Scenario A - 2020-2024
  • Table 28 - Global Markets Dynamics by Revenue Source [%]: Scenario A - 2020-2024
  • Table 29 - Global Market Size by Revenue Source [$M] Scenario B - 2020-2024
  • Table 30 - Global Markets Dynamics by Revenue Source [%]: Scenario B - 2020-2024
  • Table 31 - Regional Markets Size [$M]: Scenario A - 2020-2024
  • Table 32 - Regional Markets Dynamics by Region [%]: Scenario A - 2020-2024
  • Table 33 - Regional Markets Size [$M]: Scenario B - 2020-2024
  • Table 34 - Regional Markets Dynamics [%]: Scenario B - 2020-2024
  • Table 35 - National Markets Size [$M]: Scenario A - 2020-2024
  • Table 36 - National Markets Dynamics [%]: Scenario A - 2020-2024
  • Table 37 - National Markets Size [$M]: Scenario B - 2020-2024
  • Table 38 - National Markets Dynamics [%]: Scenario B - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 2

  • Table 1 - Adult Vaccine 2020-2021 Price List
  • Table 2 - Adult Influenza Vaccine 2020-2021 Price List
  • Table 3 - Vaccines Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 4 - Vaccines Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 5 - Therapeutic Drugs Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 6 - Therapeutic Drugs Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 7 - Other Pharma Industry Products Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 8 - Other Pharma Industry Products Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 9 - PCR Instrumentation & Software Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 10 - PCR Instrumentation & Software Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 11 - Robotic PCR Systems & Software Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 12 - Robotic PCR Systems & Software Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 13 - PCR Reagents & Consumables Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 14 - PCR Reagents & Consumables Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 15 - Nose & Mouth Swabs Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 16 - Nose & Mouth Swabs Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 17 - Self-collection PCR Test Kits Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 18 - Self-collection PCR Test Kits Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 19 - Serologic Test Kits Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 20 - Serologic Test Kits Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 21 - Standoff Thermometry Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 22 - Standoff Thermometry Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 23 - X-Ray Procedures Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 24 - X-Ray Procedures Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 25 - CT Procedures Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 26 - CT Procedures Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 27 - Ultrasound Procedures Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 28 - Ultrasound Procedures Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 29 - FDG-PET/CT Procedures & Wastewater Testing Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 30 - FDG-PET/CT Procedures & Wastewater Testing Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 31 - PACS & Teleradiology Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 32 - PACS & Teleradiology Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 33 - PPE Gowns Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 34 - PPE Gowns Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 35 - Gloves Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 36 - Gloves Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 37 - Face Masks Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 38 - Face Masks Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 39 - Medical Face Shields Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 40 - Medical Face Shields Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 41 - Eye Protection Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 42 - Eye Protection Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 43 - PPE Sterilization: Systems & Consumables Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 44 - PPE Sterilization: Systems & Consumables Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 45 - Hand & Surface Sanitizers Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 46 - Hand & Surface Sanitizers Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 47 - Decontamination Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 48 - Decontamination Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 49 - Other Personal Protection Gear Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 50 - Other Personal Protection Gear Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 51 - AI, Big Data & Deep Learning Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 52 - AI, Big Data & Deep Learning Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 53 - Homecare IT Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 54 - Homecare IT Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 55 - Use of Pandemic Geo-Location Data by Country
  • Table 56 - Geo-Surveillance Systems & Services Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 57 - Geo-Surveillance Systems & Services Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 58 - E-Health Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 59 - E-Health Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 60 - Blockchain Technologies Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 61 - Blockchain Technologies Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 62 - Other ICT Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 63 - Other ICT Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 64 - Procurement Contracts on Non-Invasive Ventilators with Ten Vendors
  • Table 65 - Noninvasive Ventilators Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 66 - Noninvasive Ventilators Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 67 - Invasive Mechanical Ventilators Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 68 - Invasive Mechanical Ventilators Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 69 - Next Generation Ventilators Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 70 - Next Generation Ventilators Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 71 - Homecare "ICU" (Equipment, Software, Services) Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 72 - Homecare "ICU" (Equipment, Software, Services) Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 73 - Mobile Ventilators Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 74 - Mobile Ventilators Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 75 - Surge Capacity Hospitals Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 76 - Surge Capacity Hospitals Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 77 - Kidney Dialysis Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 78 - Kidney Dialysis Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 79 - Extracorporeal Membrane Oxygenation Procedures Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 80 - Extracorporeal Membrane Oxygenation Procedures Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 81 - Other Intensive Care Modalities Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 82 - Other Intensive Care Modalities Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 83 - Gowns Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 84 - Gowns Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 85 - Gloves Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 86 - Gloves Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 87 - Face Masks Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 88 - Face Masks Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 89 - Face Shields Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 90 - Face Shields Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 91 - Serologic Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 92 - Serologic Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 93 - Melt-Blown PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 94 - Melt-Blown PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 95 - Spun-Bond PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 96 - Spun-Bond PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 97 - Self-collection PCR Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 98 - Self-collection PCR Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 99 - Ventilators Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 100 - Ventilators Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 101 - PCR Reagents Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 102 - PCR Reagents Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 103 - PCR Systems Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 104 - PCR Systems Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 105 - Nose & Mouth Swabs Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 106 - Nose & Mouth Swabs Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 107 - Medical Glass & Other Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 108 - Medical Glass & Other Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 109 - R&D Equipment & Consumables Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 110 - R&D Equipment & Consumables Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024
  • Table 111 - Medical Glass and Other Products & Services Market Size, Market Dynamics & Market Share: Scenario A - 2020-2024
  • Table 112 - Medical Glass and Other Products & Services Market Size, Market Dynamics & Market Share: Scenario B - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 3

  • Table 1 - Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario A - 2020-2024
  • Table 2 - Hospitals and Surge Hospitals Market Dynamics by Region [%]: Scenario A - 2020-2024
  • Table 3 - Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario B - 2020-2024
  • Table 4 - Hospitals and Surge Hospitals Market Dynamics by Region [%]: Scenario B - 2020-2024
  • Table 5 - Clinical Labs Market Size by Region [$M]: Scenario A - 2020-2024
  • Table 6 - Clinical Labs Market Dynamics by Region [%]: Scenario A - 2020-2024
  • Table 7 - Clinical Labs Market Size by Region [$M]: Scenario B - 2020-2024
  • Table 8 - Clinical Labs Market Dynamics by Region [%]: Scenario B - 2020-2024
  • Table 9 - Clinics Market Size by Region [$M]: Scenario A - 2020-2024
  • Table 10 - Clinics Market Dynamics by Region [%]: Scenario A - 2020-2024
  • Table 11 - Clinics Market Size by Region [$M]: Scenario B - 2020-2024
  • Table 12 - Clinics Market Dynamics by Region [%]: Scenario B - 2020-2024
  • Table 13 - Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario A - 2020-2024
  • Table 14 - Emergency Medical Services (EMS) Market Dynamics by Region [%]: Scenario A - 2020-2024
  • Table 15 - Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario B - 2020-2024
  • Table 16 - Emergency Medical Services (EMS) Market Dynamics by Region [%]: Scenario B - 2020-2024
  • Table 17 - Homecare & Nursing Homes Market Size by Region [$M]: Scenario A - 2020-2024
  • Table 18 - Homecare & Nursing Homes Market Dynamics by Region [%]: Scenario A - 2020-2024
  • Table 19 - Homecare & Nursing Homes Market Size by Region [$M]: Scenario B - 2020-2024
  • Table 20 - Homecare & Nursing Homes Market Dynamics by Region [%]: Scenario B - 2020-2024
  • Table 21 - Research Bodies Market Size by Region [$M]: Scenario A - 2020-2024
  • Table 22 - Research Bodies Market Dynamics by Region [%]: Scenario A - 2020-2024
  • Table 23 - Research Bodies Market Size by Region [$M]: Scenario B - 2020-2024
  • Table 24 - Research Bodies Market Dynamics by Region [%]: Scenario B - 2020-2024
  • Table 25 - North America Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Table 26 - North America Vertical Markets' Dynamics [%]: Scenario A - 2020-2024
  • Table 27 - North America Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Table 28 - North America Vertical Markets' Dynamics [%]: Scenario B - 2020-2024
  • Table 29 - North America Market Size by Revenue Source [$M] Scenario A - 2020-2024
  • Table 30 - North America Markets Dynamics by Revenue Source [%]: Scenario A - 2020-2024
  • Table 31 - North America Market Size by Revenue Source [$M] Scenario B - 2020-2024
  • Table 32 - North America Markets Dynamics by Revenue Source [%]: Scenario B - 2020-2024
  • Table 33 - Europe Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Table 34 - Europe Vertical Markets' Dynamics [%]: Scenario A - 2020-2024
  • Table 35 - Europe Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Table 36 - Europe Vertical Markets' Dynamics [%]: Scenario B - 2020-2024
  • Table 37 - Europe Market Size by Revenue Source [$M] Scenario A - 2020-2024
  • Table 38 - Europe Markets Dynamics by Revenue Source [%]: Scenario A - 2020-2024
  • Table 39 - Europe Market Size by Revenue Source [$M] Scenario B - 2020-2024
  • Table 40 - Europe Markets Dynamics by Revenue Source [%]: Scenario B - 2020-2024
  • Table 41 - Asia-Pacific Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Table 42 - Asia-Pacific Vertical Markets' Dynamics [%]: Scenario A - 2020-2024
  • Table 43 - Asia-Pacific Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Table 44 - Asia-Pacific Vertical Markets' Dynamics [%]: Scenario B - 2020-2024
  • Table 45 - Asia-Pacific Market Size by Revenue Source [$M] Scenario A - 2020-2024
  • Table 46 - Asia-Pacific Markets Dynamics by Revenue Source [%]: Scenario A - 2020-2024
  • Table 47 - Asia-Pacific Market Size by Revenue Source [$M] Scenario B - 2020-2024
  • Table 48 - Asia-Pacific Markets Dynamics by Revenue Source [%]: Scenario B - 2020-2024
  • Table 49 - MEA & Latin America Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Table 50 - MEA & Latin America Vertical Markets' Dynamics [%]: Scenario A - 2020-2024
  • Table 51 - MEA & Latin America Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Table 52 - MEA & Latin America Vertical Markets' Dynamics [%]: Scenario B - 2020-2024
  • Table 53 - MEA & Latin America Market Size by Revenue Source [$M] Scenario A - 2020-2024
  • Table 54 - MEA & Latin America Markets Dynamics by Revenue Source [%]: Scenario A - 2020-2024
  • Table 55 - MEA & Latin America Market Size by Revenue Source [$M] Scenario B - 2020-2024
  • Table 56 - MEA & Latin America Markets Dynamics by Revenue Source [%]: Scenario B - 2020-2024
  • Table 57 - USA Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 58 - USA Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 59 - Canada Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 60 - Canada Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 61 - U.K. Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 62 - U.K. Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 63 - Germany Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 64 - Germany Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 65 - France Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 66 - France Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 67 - Italy Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 68 - Italy Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 69 - Rest of Europe Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 70 - Rest of Europe Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 71 - India Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 72 - India Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 73 - China Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 74 - China Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 75 - South Korea Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 76 - South Korea Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 77 - Japan Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 78 - Japan Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 79 - Rest of Asia-Pacific Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 80 - Rest of Asia-Pacific Market Size, Dynamics and Share: Scenario B - 2020-2024
  • Table 81 - ROW Market Size, Dynamics and Share: Scenario A - 2020-2024
  • Table 82 - ROW Market Size, Dynamics and Share: Scenario B - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 4

This Volume contains no tables.

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 5

  • Table 1 - Summary of Findings for the Main Comparison. PPE-Types: One Type of PPE versus Another - PAPR versus E-RCP Attire
  • Table 2 - Summary of Findings 2. PPE Types: One Type of PPE versus Another - Three Types of PPE Attire
  • Table 3 - Summary of Findings 3. PPE Types: One Type of PPE versus Another - Gowns versus Aprons
  • Table 4 - Summary of Findings 5. PPE Types: One Type of PPE versus Another - Sealed Suit Compared To Traditional Suit
  • Table 5 - Summary of Findings 6. Procedures: Doffing With Double Gloves versus Doffing With Single Gloves
  • Table 6 - Summary of Findings 8. Procedures: Mask Tabs versus No Mask Tabs
  • Table 7 - Summary of Findings 9. Procedures: Doffing According To CDC Method versus Individual Doffing
  • Table 8 - Summary of Findings 10. Procedures: Doffing With Hypochlorite versus Doffing With Alcohol-Based Glove Sanitizer
  • Table 9 - Summary of Findings 11. Procedures: Doffing With Chlorine Spray versus Doffing Without Spray
  • Table 10 - Summary of Findings 12. Teaching: Video-Based Learning versus Traditional Lecture
  • Table 11 - CDC Vaccine 2020-2021 Price List
  • Table 12 - CDC Influenza Vaccine 2020-2021 Price List
  • Table 13 - The OECD Global Economic Outlook Forecast, 2019-2021

List of Figures

COVID-19 Pandemic Mitigation Products Market - Volume 1

  • Figure 1 - Mortality Rate Comparison, MERS, SARS & COVID-19
  • Figure 2 - COVID-19 Vs. Other Pandemics: Ro & Fatality Rate
  • Figure 3 - The Effect of the PRC Draconic Social Distancing Policy
  • Figure 4 - Healthcare Expenditure [$B] by County - 2019
  • Figure 5 - Lower and Delay the Pandemic Peak Strategy
  • Figure 6 - The 10 Countries with the Most Foreign Drug Establishments Shipping to the United States as of 2019, by Country
  • Figure 7 - Number of (2019) Intensive Care Beds [000] by Country
  • Figure 8 - ICU Beds (2019) Per 100,000 Inhabitants, by Country
  • Figure 9 - The WHO Research Funding ($8.5 Billion) Allocation
  • Figure 10 - A Serologic Test Kit
  • Figure 11 - Modeling COVID-19 Pandemic: 'Uncertainty is the Only Certainty'
  • Figure 12 - The Way an Application Detects a Person w/o Symptoms
  • Figure 13 - Countries Enacting Geo-Surveillance Services to Mitigate the COVID-19 Pandemic
  • Figure 14 - COVID-19 Pandemic Impact on Global Economics & Geopolitics
  • Figure 15 - Global COVID-19 Pandemic Mitigation Products Market Vectors
  • Figure 16 - Global Products & Services Groups Markets' Size [$M]: Scenario A - 2020-2024
  • Figure 17 - Global Products & Services Groups Markets' Size [$M]: Scenario B - 2020-2024
  • Figure 18 - Global Products & Services Markets' Size [$M]: Scenarios A and B - 2020-2024
  • Figure 19 - The SARS CoV 2 Virus
  • Figure 20 - Epidemics & Pandemics Historical Timeline
  • Figure 21 - COVID-19 Ro & Fatality Rate Vs. Other Pandemics Ro & Fatality Rate
  • Figure 22 - How Herd Immunity Can Stop the COVID-19
  • Figure 23 - The Effect of an Pandemic Early Stage Using "Social Distancing" Measures
  • Figure 24 - The SARS CoV 2, Size, Content, Genome and Replication Timescales
  • Figure 25 - Serology Test Process
  • Figure 26: COVID-19 Pandemic Mitigation Products Industry Value Chain
  • Figure 27 - COVID-19 Pandemic Mitigation Products Security Systems Market Competitive Analysis
  • Figure 28 - Global Products & Services Groups Markets' Size [$M]: Scenario A - 2020-2024
  • Figure 29 - Global Products & Services Groups Market Shares [%]: Scenario A - 2020-2024
  • Figure 30 - Global Products & Services Groups Markets' Size [$M]: Scenario B - 2020-2024
  • Figure 31 - Global Products & Services Groups Market Shares [%]: Scenario B - 2020-2024
  • Figure 32 - Global COVID-19 Mitigation Market Size [$M]: Scenarios A and B - 2020-2024
  • Figure 33 - Global Products & Services Markets' Size [$M]: Scenarios A and B - 2020-2024
  • Figure 34 - Global Vertical Markets' Shares [%]: Scenario A - 2020-2024
  • Figure 35 - Global Vertical Markets' Shares [%]: Scenario B - 2020-2024
  • Figure 36 - Global Vertical Markets' Size [$M]: Scenarios A and B - 2020-2024
  • Figure 37 - Global Market Shares by Revenue Source [%]: Scenario A - 2020-2024
  • Figure 38 - Global Market Shares by Revenue Source [%]: Scenario B - 2020-2024
  • Figure 39 - Global Revenue Sources [$M]: Scenarios A and B - 2020-2024
  • Figure 40 - Regional Market Shares [%]: Scenario A - 2020-2024
  • Figure 41 - Regional Market Shares [%]: Scenario B - 2020-2024
  • Figure 42 - Regional Markets' Size [$M]: Scenarios A and B - 2020-2024
  • Figure 43 - National Markets Size [$M]: Scenario A - 2020-2024
  • Figure 44 - National Markets Shares [%]: Scenario A - 2020-2024
  • Figure 45 - National Markets Size [$M]: Scenario B - 2020-2024
  • Figure 46 - National Markets Shares [%]: Scenario B - 2020-2024
  • Figure 47 - COVID-19 National Markets Size [$M]: Scenarios A and B - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 2

  • Figure 1 - Vaccine Development: Traditional Timeline vs. COVID-19 Accelerated Timeline
  • Figure 2 - COVID-19 Vaccines Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • Figure 3 - Vaccines Market Size [$M] by Scenario - 2020-2024
  • Figure 4 - FDA Testing COVID-19 Treatment
  • Figure 5 - Network-Based Drug Repurposing For COVID-19
  • Figure 6 - COVID-19 Therapeutic Drug Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • Figure 7 - COVID-19 Therapeutic Drugs Market Size [$M] by Scenario - 2020-2024
  • Figure 8- Medicines Essential for ICU Care of COVID-19 Patients Are Prepped For Shipment in Direct Relief's Warehouse
  • Figure 9 - Other COVID-19 Pharma Industry Products Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • Figure 10 - Other Pharma Industry Products Market Size [$M] by Scenario - 2020-2024
  • Figure 11 - Reverse Transcription - Polymerase Chain Reaction (RT-PCR) Process
  • Figure 12- PCR Test
  • Figure 13 - PCR Thermal Amplification
  • Figure 14 - Antibody Vs. PCR Testing Methods
  • Figure 15 - RT-PCR Process
  • Figure 16 - COVID-19 PCR Components
  • Figure 17 - PCR Instrumentation & Software Market: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
  • Figure 18 - PCR Instrumentation & Software Market Size [$M] by Scenario - 2020-2024
  • Figure 19 - Robotic COVID-19 PCR Lab Can Process 1000 Patient Samples Daily
  • Figure 20 - A Robotic PCR Lab Can Provide Much Needed Testing Capacity For Those With Symptoms Consistent With COVID-19 Infection
  • Figure 21 - Thermo Fisher Robotic Based Lab Automation
  • Figure 22 - Robotic PCR Systems & Software Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • Figure 23 - Robotic PCR Systems & Software Market Size [$M] by Scenario - 2020-2024
  • Figure 24 - COVID-19 PCR Kit
  • Figure 25 - PCR Reagents & Consumables Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • Figure 26 - PCR Reagents & Consumables Market Size [$M] by Scenario - 2020-2024
  • Figure 27 - Nose & Mouth Swabs Collecting Procedure
  • Figure 28 - PCR Sample Using Nose & Mouth Swabs
  • Figure 29 - Nose & Mouth Swabs Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • Figure 30 - Nose & Mouth Swabs Market Size [$M] by Scenario - 2020-2024
  • Figure 31 - An Oral Self-Swab Kit
  • Figure 32 - Saliva Test Vials
  • Figure 33 - FDA Approved Saliva Test
  • Figure 34 - Self-collection PCR Test Kits Market Size [$M] by Scenario - 2020-2024
  • Figure 35 - A Serologic Test Kit
  • Figure 36 - How a Serologic Test Works
  • Figure 37 - Antibody Vs. PCR Testing Methods
  • Figure 38 - The Indian Government's Proposed COVID-19 Antibody Screening Flowchart
  • Figure 39 - Coronavirus Antibody Test Kit
  • Figure 40 - Coronavirus IgG Antibody Detection Kit Reading
  • Figure 41 - Serologic Test Kits Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • Figure 42 - Serologic Test Kits Market Size [$M] by Scenario - 2020-2024
  • Figure 43 - COVID-19 Standoff Thermometry Screening
  • Figure 44 - Body Temperature Measuring & Facial Recognition Access Control
  • Figure 45 - A Standoff Thermal Camera
  • Figure 46 - A Standoff Thermometer Kit
  • Figure 47 - Standoff Thermometry Market Size [$M] by Scenario - 2020-2024
  • Figure 48 - A Mobile X-Ray System
  • Figure 49 - A Series of Chest X-Ray Findings of Patient With COVID-19 Demonstrating Clinical Characteristics of Disease
  • Figure 50 - Partial Filling of Air Spaces in The Lungs From Coronavirus
  • Figure 51 - X-Ray Procedures Market Size [$M] by Scenario - 2020-2024
  • Figure 52 - The Vatech COVID-19 Dedicated CT System
  • Figure 53 - Chest CT images of A COVID-19 Patient. Top Five Days after Onset, Bottom 15 Days after Onset
  • Figure 54 - CT Procedures Market Size [$M] by Scenario - 2020-2024
  • Figure 55 - A Chest Ultrasound Procedure
  • Figure 56 - CT and Ultrasound Scans from Two COVID-19 Patients
  • Figure 57 - Ultrasound Procedures Market Size [$M] by Scenario - 2020-2024
  • Figure 58 - Peripheral GGOs with An Increased 18F-FDG Uptake In The Right Upper Lung And Left Lower Lung
  • Figure 59 - A PET-CT System
  • Figure 60 - FDG-PET/CT Procedures & Wastewater Testing Market Size [$M] by Scenario - 2020-2024
  • Figure 61- A PACS Based Infrastructure Linked to RIS, Viewing Stations HIS and Teleradiology Optimizes the Workflow
  • Figure 62 - PACS Distributed Architecture
  • Figure 63 - A Tablet Linked via Teleradiography to a COVID-19 Patient PACS Record
  • Figure 64 - PACS & Teleradiology Market Size [$M] by Scenario - 2020-2024
  • Figure 65 - A PPE Set
  • Figure 66 - Reusable ICU Gowns
  • Figure 67 - PPE Gowns Market Size [$M] by Scenario - 2020-2024
  • Figure 68 -Medical Gloves
  • Figure 69 - Gloves Market Size [$M] by Scenario - 2020-2024
  • Figure 70 - Face Masks Compared
  • Figure 71 - When to Use a Respirator or a Surgical Mask
  • Figure 72 - N95 Respirator Layers
  • Figure 73 - Face Masks Market Size [$M] by Scenario - 2020-2024
  • Figure 74 - Face Shields
  • Figure 75 - Five Protective Shields Designs
  • Figure 76 - Medical Face Shields Market Size [$M] by Scenario - 2020-2024
  • Figure 77 - Eye Protection Market Size [$M] by Scenario - 2020-2024
  • Figure 78 - PPE Sterilization: Systems & Consumables Market Size [$M] by Scenario - 2020-2024
  • Figure 79 - Hand & Surface Sanitizers Market Size [$M] by Scenario - 2020-2024
  • Figure 80 - Decontamination Market Size [$M] by Scenario - 2020-2024
  • Figure 81 - Other Personal Protection Gear Market Size [$M] by Scenario - 2020-2024
  • Figure 82 - A COVID-19 CT Image
  • Figure 83 - Signs of Pneumonia in a Chest X-ray
  • Figure 84 - COVID-19 AI, Big Data & Deep Learning Flow Diagram
  • Figure 85 - Receiver Operating Characteristic Curves of the Model
  • Figure 86 - Example of a COVID-19 Detection Neural Network
  • Figure 87 - AI, Big Data & Deep Learning Market Size [$M] by Scenario - 2020-2024
  • Figure 88 - Homecare IT Flowchart
  • Figure 89 - Homecare IT Market Size [$M] by Scenario - 2020-2024
  • Figure 90 - Urban Pandemic Geo-Location System
  • Figure 91 - Countries Enacting Geo-Surveillance Services to Mitigate the COVID-19 Pandemic by March 2020
  • Figure 92 - Cellphone Displays the Private Kit APP
  • Figure 93 - Pandemic Geo-Location System without Cell Phones
  • Figure 94 - The UK NHS COVID-19 Bluetooth App
  • Figure 95 - Hong Cong, S. Korea & Singapore who Used a COVID-19 Pandemic Geo-Surveillance Services Prove the Limited Spread of The COVID-19 Vs. Other Countries
  • Figure 96 - Face Recognition as Used in China to Augment its Pandemic Geo-Location System
  • Figure 97 - Geo-Surveillance Systems & Services Market Size [$M] by Scenario - 2020-2024
  • Figure 98 - E-Health Market Size [$M] by Scenario - 2020-2024
  • Figure 99 - Blockchain Technologies Market Size [$M] by Scenario - 2020-2024
  • Figure 100 - Other ICT Market Size [$M] by Scenario - 2020-2024
  • Figure 101 - Non-Invasive Ventilator Demonstration
  • Figure 102 - Mechanical Ventilator vs. Non-Invasive Ventilator
  • Figure 103 - Helmet-Based Non-Invasive Ventilator
  • Figure 104 - Non-Invasive Ventilators Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution
  • Figure 105 - Noninvasive Ventilators Market Size [$M] by Scenario - 2020-2024
  • Figure 106 - A Mechanical Invasive Ventilator
  • Figure 107 - General Motors / Ventec, VOCSN Multi-function Ventilators Manufactured During April 2020
  • Figure 108 - A Mechanical Ventilator Function
  • Figure 109 - System Components Layout & Function
  • Figure 110 - Invasive Mechanical Ventilators Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution
  • Figure 111 - Invasive Mechanical Ventilators Market Size [$M] by Scenario - 2020-2024
  • Figure 112 - Next Generation Ventilators Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution
  • Figure 113 - Next Generation Ventilators Market Size [$M] by Scenario - 2020-2024
  • Figure 114 - COVID-19 Homecare Elements
  • Figure 115 - Homecare "ICU" Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution
  • Figure 116 - Homecare "ICU" (Equipment, Software, Services) Market Size [$M] by Scenario - 2020-2024
  • Figure 117 - A Smiths Group Portable Ventilator
  • Figure 118 - An Invasive Portable Ventilator
  • Figure 119 - Mobile Ventilators Market Size [$M] by Scenario - 2020-2024
  • Figure 120 - Italian Red Cross Surge Hospital Unit Installed During The Fiera Di San Rocco Pandemic
  • Figure 121 - 52 Bed Surge Hospital
  • Figure 122 - A Russian Tented Surge Hospital
  • Figure 126 - Surge Capacity Hospitals Market Size [$M] by Scenario - 2020-2024
  • Figure 127 - Kidney Dialysis Market Size [$M] by Scenario - 2020-2024
  • Figure 128 - ECMO System
  • Figure 129 - ECMO Machine Function
  • Figure 130 - Extracorporeal Oxygenation System Used for a COVID-19 Patient
  • Figure 131 - Extracorporeal Membrane Oxygenation Procedures Market Size [$M] by Scenario - 2020-2024
  • Figure 132 - Typical COVID-19 ICU Equipment
  • Figure 133 - Other Intensive Care Modalities Market Size [$M] by Scenario - 2020-2024
  • Figure 134 - Ford Manufactures Hospital Gowns with Airbag Material
  • Figure 135 - A Canadian (Canada Goose) PPE Gowns Production Line
  • Figure 136 - Gowns Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 137 - Medical gloves coating machine
  • Figure 138 - Medical PPE Gloves Manufacturing Machine
  • Figure 139 - Medical PPE Gloves Manufacturing Line
  • Figure 140 - Gloves Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 141 - A Production Line for the Manufacture Of Masks at a Factory in Shanghai
  • Figure 142 - Automatic Face Mask Making Machine
  • Figure 143 - N95 Face Mask
  • Figure 144 - A Garment Production Line Converted To Manufacture Face Masks
  • Figure 145 - An N95 Respirator Manufacturing Line
  • Figure 146 - Automatic N95 Respirator Face Mask Forming Production Machine
  • Figure 147 - Face Masks Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 148 - Face Shields Manufacturing Line
  • Figure 149 - President Trump Visits a New Face Shield Manufacturing Line
  • Figure 150 - Face Shields Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 151 - Test Kits Manufacturing
  • Figure 152 - Test Kits Assembly Line
  • Figure 153 - Serologic Test Kits Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 154 - Medical Grade Gown Made Of Melt-Blown Fabric
  • Figure 155 - Melt-Blown PPE Fabric Manufacturing Machine
  • Figure 156 - Production Lines: Three Spun-Bonded Lines, One Melt-Blown Non-Woven Line and Three Lamination Lines, Producing Melt-Blown Material
  • Figure 157 - Melt-Blown PPE Fabric Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 158 - Spun-Bond Manufacturing Method
  • Figure 159 - Spun-Bond Based Medical PPE
  • Figure 160 - Spun Bond Manufacturing Machine
  • Figure 161 - Spun-Bond PPE Fabric Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 31 - A self-collection PCR sample Kit
  • Figure 162 - Self-collection PCR Test Kits Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 163 - Ventilators Production Line
  • Figure 164 - ICU Ventilators per 100,000 People Over 65
  • Figure 165 - Ventilators Production Final Test Stage
  • Figure 166 - A German Ventilators Production Line
  • Figure 167 - Ventilators Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 168 - PCR Reagents Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 169 - PCR Systems Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 170 - Swabs Manufactures Machine
  • Figure 171 - Swabs Manufacturing Plant
  • Figure 172 - Nose & Mouth Swabs Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 173 - Medical Glass & Other Manufacturing Plants Market Size [$M] by Scenario - 2020-2024
  • Figure 174 - R&D Equipment & Consumables Market Size [$M] by Scenario - 2020-2024
  • Figure 175 - Medical Glass and Other Products & Services Market Size [$M] by Scenario - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 3

  • Figure 1 - Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario A - 2020-2024
  • Figure 2 - Hospitals and Surge Hospitals Market Shares by Region [%]: Scenario A - 2020-2024
  • Figure 3 - Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario B - 2020-2024
  • Figure 4 - Hospitals and Surge Hospitals Market Shares by Region [%]: Scenario B - 2020-2024
  • Figure 5 - Hospitals and Surge Hospitals Markets Size [$M]: Scenarios A and B - 2020-2024
  • Figure 6 - Clinical Labs Market Size by Region [$M]: Scenario A - 2020-2024
  • Figure 7 - Clinical Labs Market Shares by Region [%]: Scenario A - 2020-2024
  • Figure 8 - Clinical Labs Market Size by Region [$M]: Scenario B - 2020-2024
  • Figure 9 - Clinical Labs Market Shares by Region [%]: Scenario B - 2020-2024
  • Figure 10 - Clinical Labs Market Size [$M]: Scenarios A and B - 2020-2024
  • Figure 11 - Clinics Market Size by Region [$M]: Scenario A - 2020-2024
  • Figure 12 - Clinics Market Shares by Region [%]: Scenario A - 2020-2024
  • Figure 13 - Clinics Market Size by Region [$M]: Scenario B - 2020-2024
  • Figure 14 - Clinics Market Shares by Region [%]: Scenario B - 2020-2024
  • Figure 15 - Clinics Market Size [$M]: Scenarios A and B - 2020-2024
  • Figure 16 - Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario A - 2020-2024
  • Figure 17 - Emergency Medical Services (EMS) Market Shares by Region [%]: Scenario A - 2020-2024
  • Figure 18 - Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario B - 2020-2024
  • Figure 19 - Emergency Medical Services (EMS) Market Shares by Region [%]: Scenario B - 2020-2024
  • Figure 20 - Emergency Medical Services Market Size [$M]: Scenarios A and B - 2020-2024
  • Figure 21 - Homecare & Nursing Homes Market Size by Region [$M]: Scenario A - 2020-2024
  • Figure 22 - Homecare & Nursing Homes Market Shares by Region [%]: Scenario A - 2020-2024
  • Figure 23 - Homecare & Nursing Homes Market Size by Region [$M]: Scenario B - 2020-2024
  • Figure 24 - Homecare & Nursing Homes Market Shares by Region [%]: Scenario B - 2020-2024
  • Figure 25 - Homecare & Nursing Homes Market Size [$M]: Scenarios A and B - 2020-2024
  • Figure 26 - Research Bodies Market Size by Region [$M]: Scenario A - 2020-2024
  • Figure 27 - Research Bodies Market Shares by Region [%]: Scenario A - 2020-2024
  • Figure 28 - Research Bodies Market Size by Region [$M]: Scenario B - 2020-2024
  • Figure 29 - Research Bodies Market Shares by Region [%]: Scenario B - 2020-2024
  • Figure 30 - Research Bodies Market Size [$M]: Scenarios A and B - 2020-2024
  • Figure 31 - North America Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Figure 32 - North America Vertical Markets' Shares [%]: Scenario A - 2020-2024
  • Figure 33 - North America Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Figure 34 - North America Vertical Markets' Shares [%]: Scenario B - 2020-2024
  • Figure 35 - North America COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B
  • Figure 36 - North America Market Shares by Revenue Source [%]: Scenario A - 2020-2024
  • Figure 37 - North America Market Shares by Revenue Source [%]: Scenario B - 2020-2024
  • Figure 38 - Europe Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Figure 39 - Europe Vertical Markets' Shares [%]: Scenario A - 2020-2024
  • Figure 40 - Europe Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Figure 41 - Europe Vertical Markets' Shares [%]: Scenario B - 2020-2024
  • Figure 42 - Europe COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B
  • Figure 43 - Europe Market Shares by Revenue Source [%]: Scenario A - 2020-2024
  • Figure 44 - Europe Market Shares by Revenue Source [%]: Scenario B - 2020-2024
  • Figure 45 - Asia-Pacific Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Figure 46 - Asia-Pacific Vertical Markets' Shares [%]: Scenario A - 2020-2024
  • Figure 47 - Asia-Pacific Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Figure 48 - Asia-Pacific Vertical Markets' Shares [%]: Scenario B - 2020-2024
  • Figure 49 - Asia-Pacific COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B
  • Figure 50 - Asia-Pacific Market Shares by Revenue Source [%]: Scenario A - 2020-2024
  • Figure 51 - Asia-Pacific Market Shares by Revenue Source [%]: Scenario B - 2020-2024
  • Figure 52 - MEA & Latin America Vertical Markets' Size [$M]: Scenario A - 2020-2024
  • Figure 53 - MEA & Latin America Vertical Markets' Shares [%]: Scenario A - 2020-2024
  • Figure 54 - MEA & Latin America Vertical Markets' Size [$M]: Scenario B - 2020-2024
  • Figure 55 - MEA & Latin America Vertical Markets' Shares [%]: Scenario B - 2020-2024
  • Figure 56 - MEA & Latin America COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B
  • Figure 57 - MEA & Latin America Market Shares by Revenue Source [%]: Scenario A - 2020-2024
  • Figure 58 - MEA & Latin America Market Shares by Revenue Source [%]: Scenario B - 2020-2024
  • Figure 59 - U.S. Confirmed Cases per Million Residents by State as of May 26, 2020
  • Figure 60 - USA Market Size [$M] by Scenario - 2020-2024
  • Figure 61 - Canada Confirmed Cases per Million Residents by Province/Territory as of May 26, 2020
  • Figure 62 - Canada Market Size [$M] by Scenario - 2020-2024
  • Figure 63 - U.K. Confirmed Cases per Ten Thousand Residents as of May 26, 2020
  • Figure 64 - U.K. Market Size [$M] by Scenario - 2020-2024
  • Figure 65 - Germany Confirmed Cases per 10,000 Inhabitants by District
  • Figure 66 - Germany Market Size [$M] by Scenario - 2020-2024
  • Figure 67 - France Deaths per Million Residents by Department
  • Figure 68 - France Market Size [$M] by Scenario - 2020-2024
  • Figure 69 - Italy Confirmed Cases per Million Residents by Province (as of 25 May 2020)
  • Figure 70 - Italy Market Size [$M] by Scenario - 2020-2024
  • Figure 71 - Rest of Europe Market Size [$M] by Scenario - 2020-2024
  • Figure 72 - Map of the Pandemic in India (as of 28 May 2020)
  • Figure 73 - India Market Size [$M] by Scenario - 2020-2024
  • Figure 74 - Confirmed COVID-19 Cases in Mainland China per Million Inhabitants by Province as of 13 April 2020
  • Figure 75 - China Market Size [$M] by Scenario - 2020-2024
  • Figure 76 - Confirmed Cases per Million Residents by Province or City in South Korea
  • Figure 77 - South Korea Market Size [$M] by Scenario - 2020-2024
  • Figure 78 - Japan Confirmed Cases per Million Residents by Prefecture
  • Figure 79 - Japan Market Size [$M] by Scenario - 2020-2024
  • Figure 80 - Rest of Asia-Pacific Market Size [$M] by Scenario - 2020-2024
  • Figure 81 - ROW Market Size [$M] by Scenario - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 4

This volume contains no figures.

COVID-19 Pandemic Mitigation Products Market - 2020-2024 - Volume 5

  • Figure 1 - Hierarchy of Controls
  • Figure 2 - France National Stockpile of Face Masks
  • Figure 3 - Polymerase Chain Reaction Overview
  • Figure 4 - Industry Enabled Stabilization of Supply Chain
  • Figure 5 - Project Air Bridge
  • Figure 6 - Most Cases are never Counted
  • Figure 7 - The Difference between A PCR Test and an Antibody Test
  • Figure 8 - Capital Flows to Emerging Markets in Global Shocks
  • Figure 9 - Depreciation Against the Dollar Since Jan. 1, 2020